Applied Materials (AMAT) 10-Q 22 Aug 24 2024 Q3 Quarterly report Financial data

Cover Page

Cover Page	9 Months Ended
	Jul. 28, 2024 shares
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 28, 2024
Document Transition Report	false
Entity File Number	000-06920
Entity Registrant Name	APPLIED MATERIALS INC /DE
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	94-1655526
Entity Address, Address Line One	3050 Bowers Avenue
Entity Address, Address Line Two	P.O. Box 58039
Entity Address, City or Town	Santa Clara
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95052-8039
City Area Code	408
Local Phone Number	727-5555
Title of 12(b) Security	Common Stock, par value $.01 per share
Trading Symbol	AMAT
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	824,404,088
Entity Central Index Key	0000006951
Current Fiscal Year End Date	--10-27
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Amendment Flag	false

Consolidated Condensed Statemen

Consolidated Condensed Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023
Income Statement [Abstract]
Net revenue	$ 6,778	$ 6,425	$ 20,131	$ 19,794
Cost of products sold	3,573	3,449	10,569	10,579
Gross profit	3,205	2,976	9,562	9,215
Operating expenses:
Research, development and engineering	836	767	2,375	2,313
Marketing and selling	205	193	621	584
General and administrative	222	214	745	635
Total operating expenses	1,263	1,174	3,741	3,532
Income from operations	1,942	1,802	5,821	5,683
Interest expense	63	60	181	180
Interest and other income (expense), net	81	64	617	41
Income before income taxes	1,960	1,806	6,257	5,544
Provision for income taxes	255	246	811	692
Net income	$ 1,705	$ 1,560	$ 5,446	$ 4,852
Earnings per share:
Basic (in dollars per share)	$ 2.06	$ 1.86	$ 6.57	$ 5.76
Diluted (in dollars per share)	$ 2.05	$ 1.85	$ 6.52	$ 5.73
Weighted average number of shares:
Basic (in shares)	826	838	829	842
Diluted (in shares)	833	843	835	846

Consolidated Condensed Statem_2

Consolidated Condensed Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 1,705	$ 1,560	$ 5,446	$ 4,852
Other comprehensive income (loss), net of tax:
Change in unrealized gain (loss) on available-for-sale investments	18	(3)	36	25
Change in unrealized net loss on derivative instruments	8	15	44	(46)
Change in defined and postretirement benefit plans	0	0	(9)	0
Other comprehensive income (loss), net of tax	26	12	71	(21)
Comprehensive income	$ 1,731	$ 1,572	$ 5,517	$ 4,831

Consolidated Condensed Balance

Consolidated Condensed Balance Sheets - USD ($) $ in Millions	Jul. 28, 2024	Oct. 29, 2023
Current assets:
Cash and cash equivalents	$ 8,288	$ 6,132
Short-term investments	815	737
Accounts receivable, net	4,970	5,165
Inventories	5,568	5,725
Other current assets	1,030	1,388
Total current assets	20,671	19,147
Long-term investments	2,981	2,281
Property, plant and equipment, net	3,100	2,723
Goodwill	3,732	3,732
Purchased technology and other intangible assets, net	262	294
Deferred income taxes and other assets	2,901	2,552
Total assets	33,647	30,729
Current liabilities:
Short-term debt	99	100
Accounts payable and accrued expenses	4,387	4,297
Contract liabilities	2,742	2,975
Total current liabilities	7,228	7,372
Long-term debt	6,158	5,461
Income taxes payable	671	833
Other liabilities	750	714
Total liabilities	14,807	14,380
Stockholders’ equity:
Common stock	8	8
Additional paid-in capital	9,428	9,131
Retained earnings	48,247	43,726
Treasury stock	(38,697)	(36,299)
Accumulated other comprehensive loss	(146)	(217)
Total stockholders’ equity	18,840	16,349
Total liabilities and stockholders’ equity	$ 33,647	$ 30,729

Consolidated Condensed Statem_3

Consolidated Condensed Statements of Stockholders' Equity - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Additional Paid-In Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Oct. 30, 2022		844
Beginning balance at Oct. 30, 2022	$ 12,194	$ 8	$ 8,593	$ 37,892	$ (34,097)	$ (202)
Treasury stock, beginning balance (in shares) at Oct. 30, 2022					1,173
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	4,852			4,852
Other comprehensive income (loss), net of tax	(21)					(21)
Dividends declared	(756)			(756)
Share-based compensation	375		375
Net issuance under stock plans (in shares)		5
Net issuance under stock plans	$ (54)		(54)
Common stock repurchases (in shares)	(13)	(13)			(13)
Common stock repurchases	$ (1,497)				$ (1,497)
Ending balance (in shares) at Jul. 30, 2023		836
Ending balance at Jul. 30, 2023	15,093	$ 8	8,914	41,988	$ (35,594)	(223)
Treasury stock, ending balance (in shares) at Jul. 30, 2023					1,186
Beginning balance (in shares) at Apr. 30, 2023		840
Beginning balance at Apr. 30, 2023	14,129	$ 8	8,811	40,696	$ (35,151)	(235)
Treasury stock, beginning balance (in shares) at Apr. 30, 2023					1,182
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,560			1,560
Other comprehensive income (loss), net of tax	12					12
Dividends declared	(268)			(268)
Share-based compensation	114		114
Net issuance under stock plans	$ (11)		(11)
Common stock repurchases (in shares)	(4)	(4)			(4)
Common stock repurchases	$ (443)				$ (443)
Ending balance (in shares) at Jul. 30, 2023		836
Ending balance at Jul. 30, 2023	15,093	$ 8	8,914	41,988	$ (35,594)	(223)
Treasury stock, ending balance (in shares) at Jul. 30, 2023					1,186
Beginning balance (in shares) at Oct. 29, 2023		833
Beginning balance at Oct. 29, 2023	16,349	$ 8	9,131	43,726	$ (36,299)	(217)
Treasury stock, beginning balance (in shares) at Oct. 29, 2023					1,191
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	5,446			5,446
Other comprehensive income (loss), net of tax	71					71
Dividends declared	(925)			(925)
Share-based compensation	436		436
Net issuance under stock plans (in shares)		4
Net issuance under stock plans	$ (139)		(139)
Common stock repurchases (in shares)	(13)	(13)			(13)
Common stock repurchases	$ (2,398)				$ (2,398)
Ending balance (in shares) at Jul. 28, 2024		824
Ending balance at Jul. 28, 2024	18,840	$ 8	9,428	48,247	$ (38,697)	(146)
Treasury stock, ending balance (in shares) at Jul. 28, 2024					1,204
Beginning balance (in shares) at Apr. 28, 2024		828
Beginning balance at Apr. 28, 2024	18,199	$ 8	9,321	46,871	$ (37,829)	(172)
Treasury stock, beginning balance (in shares) at Apr. 28, 2024					1,200
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,705			1,705
Other comprehensive income (loss), net of tax	26					26
Dividends declared	(329)			(329)
Share-based compensation	132		132
Net issuance under stock plans	$ (25)		(25)
Common stock repurchases (in shares)	(4)	(4)			(4)
Common stock repurchases	$ (868)				$ (868)
Ending balance (in shares) at Jul. 28, 2024		824
Ending balance at Jul. 28, 2024	$ 18,840	$ 8	$ 9,428	$ 48,247	$ (38,697)	$ (146)
Treasury stock, ending balance (in shares) at Jul. 28, 2024					1,204

Consolidated Condensed Statem_4

Consolidated Condensed Statements of Stockholders' Equity (Parenthetical) - $ / shares	1 Months Ended			3 Months Ended		9 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023
Statement of Stockholders' Equity [Abstract]
Dividends declared per share (in dollars per share)	$ 0.40	$ 0.40	$ 0.32	$ 0.40	$ 0.32	$ 1.12	$ 0.90

Consolidated Condensed Statem_5

Consolidated Condensed Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023
Cash flows from operating activities:
Net income	$ 5,446	$ 4,852
Adjustments required to reconcile net income to cash provided by operating activities:
Depreciation and amortization	282	385
Share-based compensation	436	375
Deferred income taxes	(385)	(174)
Other	(199)	189
Changes in operating assets and liabilities:
Accounts receivable	195	838
Inventories	157	123
Other current and non-current assets	353	27
Accounts payable and accrued expenses	(20)	(441)
Contract liabilities	(233)	355
Income taxes payable	46	545
Other liabilities	24	71
Cash provided by operating activities	6,102	7,145
Cash flows from investing activities:
Capital expenditures	(783)	(797)
Cash paid for acquisitions, net of cash acquired	0	(25)
Proceeds from sales and maturities of investments	1,495	971
Purchases of investments	(1,968)	(1,195)
Cash used in investing activities	(1,256)	(1,046)
Cash flows from financing activities:
Debt borrowings, net of issuance costs	694	0
Proceeds from issuance of commercial paper	300	892
Repayments of commercial paper	(300)	(700)
Proceeds from common stock issuances	119	111
Common stock repurchases	(2,381)	(1,489)
Tax withholding payments for vested equity awards	(258)	(165)
Payments of dividends to stockholders	(863)	(707)
Repayments of principal on finance leases	(12)	(8)
Cash used in financing activities	(2,701)	(2,066)
Increase (decrease) in cash, cash equivalents and restricted cash equivalents	2,145	4,033
Cash, cash equivalents and restricted cash equivalents — beginning of period	6,233	2,100
Cash, cash equivalents and restricted cash equivalents — end of period	8,378	6,133
Reconciliation of cash, cash equivalents and restricted cash equivalents
Cash and cash equivalents	8,288	6,025
Restricted cash equivalents included in deferred income taxes and other assets	90	108
Total cash, cash equivalents and restricted cash equivalents	8,378	6,133
Supplemental cash flow information:
Cash payments for income taxes	819	418
Cash refunds from income taxes	7	51
Cash payments for interest	$ 137	$ 137

Basis of Presentation

Basis of Presentation	9 Months Ended
	Jul. 28, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation Basis of Presentation In the opinion of our management, the unaudited interim consolidated condensed financial statements of Applied Materials, Inc. and its subsidiaries (we, us, and our) included herein have been prepared on a basis consistent with the October 29, 2023 audited consolidated financial statements and include all material adjustments, consisting of normal recurring adjustments, necessary to fairly state the information set forth therein. These unaudited interim consolidated condensed financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended October 29, 2023 (2023 Form 10-K). The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make judgments, estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ materially from those estimates. Our results of operations for the three and nine months ended July 28, 2024 are not necessarily indicative of future operating results. Our fiscal year ends on the last Sunday in October of each year. Fiscal 2024 and 2023 contain 52 weeks each and the first nine months of fiscal 2024 and 2023 each contained 39 weeks. Certain prior-year amounts have been reclassified to conform to current-year presentation. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make judgments, estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, we evaluate our estimates, including those related to standalone selling price (SSP) related to revenue recognition, accounts receivable and sales allowances, fair values of financial instruments, inventories, intangible assets and goodwill, useful lives of intangible assets and property, plant and equipment, fair values of share-based awards, warranty, and income taxes, among others. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Property, Plant and Equipment Property, plant and equipment is stated at cost. Depreciation is provided over the estimated useful lives of the assets using the straight-line method. In connection with our periodic review of estimated useful lives of the property, plant, and equipment effective as of the beginning of fiscal 2024, we have increased the estimated useful lives of certain assets. The updated estimated useful lives for financial reporting purposes are as follows: buildings and improvements, 3 to 30 years with certain buildings and improvements’ useful lives increased by 5 years; demonstration and manufacturing equipment increased to between 5 to 8 years. The estimated useful lives for the remaining asset categories remained unchanged from fiscal 2023. The change in accounting estimate is being applied on a prospective basis to the assets on our balance sheet as of October 29, 2023, as well as to subsequent asset purchases. Based on the net carrying amounts of assets in use as of the end of fiscal 2023, the impact of this change was a reduction of $30 million and $97 million in depreciation expense during the three and nine months ended July 28, 2024, respectively, and an increase of $0.03 and $0.09 in both basic and diluted earnings per share for the three and nine months ended July 28, 2024, respectively. Recent Accounting Pronouncements Accounting Standards Adopted Contract Assets and Contract Liabilities from Revenue Contracts with Customers in a Business Combination. In October 2021, the Financial Accounting Standards Board (FASB) issued an accounting standard update to improve the accounting for contract assets and contract liabilities from revenue contracts with customers in a business combination (Topic 805). This amendment improves comparability for both the recognition and measurement of acquired revenue contracts with customers at the date of and after a business combination. We adopted this authoritative guidance in the first quarter of fiscal 2024 and the impact of the adoption depends on the facts and circumstances of future acquisitions. Accounting Standards Not Yet Adopted Improvements to Income Tax Disclosures . In December 2023, the FASB issued an accounting standard update to improve income tax disclosures (Topic 740). The standard prescribes specific categories for the components of the effective tax rate reconciliation, requires disclosure of income taxes paid by jurisdiction, and modifies other income tax-related disclosures. This authoritative guidance will be effective for us beginning with our annual reporting for fiscal year 2026, with early adoption permitted. We are evaluating the effect of this new guidance on our consolidated financial statements and related disclosures. Improvements to Reportable Segment Disclosures . In November 2023, the FASB issued an accounting standard update to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses (Topic 280). The standard requires interim and annual disclosure of significant segment expenses that are regularly provided to the chief operating decision-maker (CODM) and included within the reported measure of a segment’s profit or loss, requires interim disclosures about a reportable segment’s profit or loss and assets that are currently required annually, requires disclosure of the position and title of the CODM, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss and contains other disclosure requirements. This authoritative guidance will be effective for us in fiscal 2025 for annual periods and in the first quarter of fiscal 2026 for interim periods, with early adoption permitted. We are evaluating the effect of this new guidance on our consolidated financial statements and related disclosures. Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. In June 2022, the FASB issued an accounting standard update which clarifies how the fair value of equity securities subject to contractual sale restrictions is determined (Topic 820). The amendment clarifies that a contractual sale restriction should not be considered in measuring fair value. It also requires certain qualitative and quantitative disclosures related to equity securities subject to contractual sale restrictions. This authoritative guidance will be effective for us in the first quarter of fiscal 2025, with early adoption permitted. The adoption of this guidance is not expected to have a significant impact on our consolidated financial statements.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Jul. 28, 2024
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share Basic earnings per share is determined using the weighted average number of common shares outstanding during the period. Diluted earnings per share is determined using the weighted average number of common shares and potential common shares (representing the dilutive effect of restricted stock units and employee stock purchase plan shares) outstanding during the period. Our net income has not been adjusted for any period presented for purposes of computing basic or diluted earnings per share due to our non-complex capital structure. Three Months Ended Nine Months Ended July 28, July 30, July 28, July 30, (In millions, except per share amounts) Numerator: Net income $ 1,705 $ 1,560 $ 5,446 $ 4,852 Denominator: Weighted average common shares outstanding 826 838 829 842 Effect of weighted dilutive restricted stock units and employee stock purchase plan shares 7 5 6 4 Denominator for diluted earnings per share 833 843 835 846 Basic earnings per share $ 2.06 $ 1.86 $ 6.57 $ 5.76 Diluted earnings per share $ 2.05 $ 1.85 $ 6.52 $ 5.73 Potentially weighted dilutive securities — — — 2 Excluded from the calculation of diluted earnings per share are securities attributable to outstanding restricted stock units where the combined exercise price and average unamortized fair value are greater than the average market price of our common stock, and therefore their inclusion would be anti-dilutive.

Cash, Cash Equivalents and Inve

Cash, Cash Equivalents and Investments	9 Months Ended
	Jul. 28, 2024
Cash and Cash Equivalents [Abstract]
Cash, Cash Equivalents and Investments	Cash, Cash Equivalents and Investments Summary of Cash, Cash Equivalents and Investments The following tables summarize our cash, cash equivalents and investments by security type: July 28, 2024 Cost Gross Gross Estimated (In millions) Cash $ 1,318 $ — $ — $ 1,318 Cash equivalents: Money market funds * 2,828 — — 2,828 Bank certificates of deposit and time deposits 20 — — 20 U.S. Treasury and agency securities 2,291 — — 2,291 Municipal securities 73 — — 73 Commercial paper, corporate bonds and medium-term notes 1,758 — — 1,758 Total cash equivalents 6,970 — — 6,970 Total cash and cash equivalents $ 8,288 $ — $ — $ 8,288 Short-term and long-term investments: Bank certificates of deposit and time deposits $ 19 $ — $ — $ 19 U.S. Treasury and agency securities 641 1 2 640 Non-U.S. government securities ** 5 — — 5 Municipal securities 445 2 4 443 Commercial paper, corporate bonds and medium-term notes 816 2 3 815 Asset-backed and mortgage-backed securities 632 1 6 627 Total fixed income securities 2,558 6 15 2,549 Publicly traded equity securities 543 422 3 962 Equity investments in privately held companies 246 58 19 285 Total equity investments 789 480 22 1,247 Total short-term and long-term investments $ 3,347 $ 486 $ 37 $ 3,796 Total cash, cash equivalents and investments $ 11,635 $ 486 $ 37 $ 12,084 _________________________ *Excludes $90 million of restricted cash equivalents invested in money market funds related to deferred compensation plans. **Includes Canadian provincial government debt. October 29, 2023 Cost Gross Gross Estimated (In millions) Cash $ 1,417 $ — $ — $ 1,417 Cash equivalents: Money market funds * 3,260 — — 3,260 Municipal securities 26 — — 26 Commercial paper, corporate bonds and medium-term notes 1,429 — — 1,429 Total cash equivalents 4,715 — — 4,715 Total cash and cash equivalents $ 6,132 $ — $ — $ 6,132 Short-term and long-term investments: Bank certificates of deposit and time deposits $ 18 $ — $ — $ 18 U.S. Treasury and agency securities 381 — 7 374 Non-U.S. government securities ** 7 — 1 6 Municipal securities 438 — 11 427 Commercial paper, corporate bonds and medium-term notes 760 — 12 748 Asset-backed and mortgage-backed securities 502 — 15 487 Total fixed income securities 2,106 — 46 2,060 Publicly traded equity securities 543 171 16 698 Equity investments in privately held companies 192 78 10 260 Total equity investments 735 249 26 958 Total short-term and long-term investments $ 2,841 $ 249 $ 72 $ 3,018 Total cash, cash equivalents and investments $ 8,973 $ 249 $ 72 $ 9,150 _________________________ *Excludes $101 million of restricted cash equivalents invested in money market funds related to deferred compensation plans. **Includes Canadian provincial government debt. During the three months ended July 28, 2024 and July 30, 2023, interest income from our cash, cash equivalents and fixed income securities was $124 million and $73 million, respectively. During the nine months ended July 28, 2024 and July 30, 2023, interest income from our cash, cash equivalents and fixed income securities was $345 million and $165 million, respectively. Maturities of Investments The following table summarizes the contractual maturities of our investments as of July 28, 2024: Cost Estimated (In millions) Due in one year or less $ 798 $ 796 Due after one through five years 1,124 1,122 Due after five years 4 4 No single maturity date* 1,421 1,874 Total $ 3,347 $ 3,796 _________________________ *Securities with no single maturity date include publicly traded and privately held equity securities and asset-backed and mortgage-backed securities. Gains and Losses on Investments During the three and nine months ended July 28, 2024 and July 30, 2023 gross realized gains and losses on our fixed income portfolio were not material. As of July 28, 2024 and October 29, 2023, gross unrealized losses related to our fixed income portfolio were not material. We regularly review our fixed income portfolio to identify and evaluate investments that have indications of possible impairment from credit losses or other factors. Factors considered in determining whether an unrealized loss is considered to be a credit loss include: the significance of the decline in value compared to the cost basis; the financial condition; credit quality and near-term prospects of the investee; and whether it is more likely than not that we will be required to sell the security prior to recovery. Credit losses related to available-for-sale debt securities are recorded as an allowance for credit losses through interest and other income (expense), net. Any additional changes in fair value that are not related to credit losses are recognized in accumulated other comprehensive income (loss) (AOCI). During the three and nine months ended July 28, 2024 and July 30, 2023, we did not recognize material credit losses and the ending allowance for credit losses was not material to our fixed income portfolio. The components of gain (loss) on equity investments for the three and nine months ended July 28, 2024 and July 30, 2023 were as follows: Three Months Ended Nine Months Ended July 28, July 30, July 28, July 30, (In millions) Publicly traded equity securities Unrealized gain $ 6 $ 12 $ 318 $ 31 Unrealized loss (30) (1) (33) (28) Realized gain on sales and dividends 3 4 5 5 Realized loss on sales or impairment — — (1) (2) Equity investments in privately held companies Unrealized gain 1 1 2 13 Unrealized loss (2) (18) (12) (29) Realized gain on sales and dividends — 2 3 7 Realized loss on sales or impairment (19) (2) (19) (119) Total gain (loss) on equity investments, net $ (41) $ (2) $ 263 $ (122)

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Jul. 28, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Our financial assets are measured and recorded at fair value on a recurring basis, except for equity investments in privately held companies. These equity investments are generally accounted for under the measurement alternative, defined as cost, less impairments, adjusted for subsequent observable price changes and are periodically assessed for impairment when events or circumstances indicate that a decline in value may have occurred. Our nonfinancial assets, such as goodwill, intangible assets, and property, plant and equipment, are recorded at cost and are assessed for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Fair Value Hierarchy We use the following fair value hierarchy, which prioritizes the inputs to valuation techniques used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: • Level 1 — Quoted prices in active markets for identical assets or liabilities; • Level 2 — Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and • Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Our investments consist primarily of debt securities that are classified as available-for-sale and recorded at their fair values. In determining the fair value of investments, we use pricing information from pricing services that value securities based on quoted market prices and models that utilize observable market inputs. In the event a fair value estimate is unavailable from a pricing service, we generally obtain non-binding price quotes from brokers. In addition, to validate pricing information obtained from pricing services, we periodically perform supplemental analysis on a sample of securities. We review any significant unanticipated differences identified through this analysis to determine the appropriate fair value. As of July 28, 2024, substantially all of our available-for-sale, short-term and long-term investments were recognized at fair value that was determined based upon observable inputs or quoted prices. Our equity investments with readily determinable values consist of publicly traded equity securities. These investments are measured at fair value using quoted prices for identical assets in an active market and the changes in fair value of these equity investments are recognized in the consolidated statements of operations. Investments with remaining effective maturities of 12 months or less from the balance sheet date are classified as short-term investments. Investments with remaining effective maturities of more than 12 months from the balance sheet date are classified as long-term investments. Assets Measured at Fair Value on a Recurring Basis Financial assets (excluding cash balances) measured at fair value on a recurring basis are summarized below: July 28, 2024 October 29, 2023 Level 1 Level 2 Total Level 1 Level 2 Total (In millions) Assets: Available-for-sale debt security investments Money market funds* $ 2,918 $ — $ 2,918 $ 3,361 $ — $ 3,361 Bank certificates of deposit and time deposits — 39 39 — 18 18 U.S. Treasury and agency securities 2,909 22 2,931 331 43 374 Non-U.S. government securities — 5 5 — 6 6 Municipal securities — 516 516 — 453 453 Commercial paper, corporate bonds and medium-term notes — 2,573 2,573 — 2,177 2,177 Asset-backed and mortgage-backed securities — 627 627 — 487 487 Total available-for-sale debt security investments $ 5,827 $ 3,782 $ 9,609 $ 3,692 $ 3,184 $ 6,876 Equity investments with readily determinable values Publicly traded equity securities $ 962 $ — $ 962 $ 698 $ — $ 698 Total equity investments with readily determinable values $ 962 $ — $ 962 $ 698 $ — $ 698 Total $ 6,789 $ 3,782 $ 10,571 $ 4,390 $ 3,184 $ 7,574 _________________________ *Amounts as of July 28, 2024 and October 29, 2023 include $90 million and $101 million, respectively, invested in money market funds related to deferred compensation plans. Due to restrictions on the distribution of these funds, they are classified as restricted cash equivalents and are included in deferred income taxes and other assets We did not have any financial assets measured at fair value on a recurring basis within Level 3 fair value measurements as of July 28, 2024 or October 29, 2023. Assets and Liabilities without Readily Determinable Values Measured on a Non-recurring Basis Our equity investments without readily determinable values consist of equity investments in privately held companies. We elected the measurement alternative, defined as cost, less impairments, adjusted for subsequent observable price changes on a prospective basis for certain equity investments without readily determinable fair values and are required to account for any subsequent observable changes in fair value within the statements of operations. These investments are classified as Level 3 within the fair value hierarchy and periodically assessed for impairment when an event or circumstance indicates that a decline in value may have occurred. Impairment losses on equity investments in privately held companies were not material during the three and nine months ended July 28, 2024. Impairment losses on equity investments in privately held companies were not material during the three months ended July 30, 2023 and were $119 million during the nine months ended July 30, 2023. These impairment losses are included in interest and other income (expense), net in the Consolidated Condensed Statement of Operations. Other The carrying amounts of our financial instruments, including cash and cash equivalents, restricted cash equivalents, accounts receivable, commercial paper notes, and accounts payable and accrued expenses, approximate fair value due to their short maturities. As of July 28, 2024, the aggregate principal amount of long-term senior unsecured notes was $6.2 billion and the estimated fair value was $5.7 billion. As of October 29, 2023, the aggregate principal amount of long-term senior unsecured notes was $5.5 billion and the estimated fair value was $4.7 billion. The estimated fair value of long-term senior unsecured notes is determined by Level 2 inputs and is based primarily on quoted market prices for the same or similar issues. See Note 10 of the Notes to the Consolidated Condensed Financial Statements for further detail of existing debt.

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities	9 Months Ended
	Jul. 28, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities	Derivative Instruments and Hedging Activities Derivative Financial Instruments We conduct business in a number of foreign countries, with certain transactions denominated in local currencies, such as the Japanese yen, Israeli shekel, euro and Taiwanese dollar. We use derivative financial instruments, such as foreign currency forward and option contracts, to hedge certain forecasted foreign currency denominated transactions expected to occur typically within the next 24 months. The purpose of our foreign currency management is to mitigate the effect of exchange rate fluctuations on certain foreign currency denominated revenues, costs and eventual cash flows. The terms of currency instruments used for hedging purposes are generally consistent with the timing of the transactions being hedged. We do not use derivative financial instruments for trading or speculative purposes. Derivative instruments and hedging activities, including foreign exchange and interest rate contracts, are recognized on the balance sheet at fair value. Changes in the fair value of derivatives that do not qualify for hedge accounting treatment are recognized currently in earnings. All of our derivative financial instruments are recorded at their fair value in other current assets or in accounts payable and accrued expenses. Hedges related to anticipated transactions are designated and documented at the inception of the hedge as cash flow hedges and foreign exchange derivatives are typically entered into once per month. Cash flow hedges are evaluated for effectiveness quarterly. The effective portion of the gain or loss on these hedges is reported as a component of AOCI in stockholders’ equity and is reclassified into earnings when the hedged transaction affects earnings. The majority of the after-tax net income or loss related to foreign exchange derivative instruments included in AOCI as of July 28, 2024 is expected to be reclassified into earnings within 12 months. Changes in fair value caused by changes in time value of option contracts designated as cash flow hedges are excluded from the assessment of effectiveness. The initial value of this excluded component is amortized on a straight-line basis over the life of the hedging instrument and recognized in the financial statement line item to which the hedge relates. If the transaction being hedged is probable not to occur, we recognize the gain or loss on the associated financial instrument in the consolidated condensed statement of operations. The amount recognized due to discontinuance of cash flow hedges that were probable of not occurring by the end of the originally specified time period was not significant for the three and nine months ended July 28, 2024 and July 30, 2023. Foreign currency forward contracts are generally used to hedge certain foreign currency denominated assets or liabilities. Accordingly, changes in the fair value of these hedges are recorded in earnings to offset the changes in the fair value of the assets or liabilities being hedged. As of July 28, 2024 and October 29, 2023, the total outstanding notional amounts of foreign exchange contracts were $1.6 billion and $1.7 billion. The fair values of foreign exchange derivative instruments as of July 28, 2024 and October 29, 2023 were not material. We are also exposed to interest rate risk associated with our potential future borrowings. During the nine months ended July 28, 2024, we entered into a series of interest rate contracts to hedge against the variability of cash flows due to changes in the benchmark interest rate of fixed rate debt. These instruments were designated as cash flow hedges at inception and were settled in conjunction with the issuance of debt in June 2024. The gain (loss) on derivatives in cash flow hedging relationships recognized in AOCI for derivatives designated as hedging instruments for the indicated periods were as follows: Three Months Ended Nine Months Ended July 28, July 30, July 28, July 30, (In millions) Derivatives in Cash Flow Hedging Relationships: Foreign exchange contracts $ 16 $ 15 $ 44 $ (32) Interest rate contracts (8) — 12 — Total $ 8 $ 15 $ 56 $ (32) The effects of derivative instruments and hedging activities on the Consolidated Condensed Statements of Operations were as follows: Three Months Ended July 28, 2024 July 30, 2023 Derivatives in Cash Flow Hedging Relationships Derivatives in Cash Flow Hedging Relationships Total Amount Presented in the Consolidated Condensed Statement of Operations in which the Effects of Cash Flow Hedges are Recorded Amount of Gain or (Loss) Amount of Gain (Loss) Excluded from Effectiveness Testing Total Amount Presented in the Consolidated Condensed Statement of Operations in which the Effects of Cash Flow Hedges are Recorded Amount of Gain or (Loss) Amount of Gain (Loss) Excluded from Effectiveness Testing (In millions) Foreign Exchange Contracts: Net revenue $ 6,778 $ 7 $ — $ 6,425 $ 8 $ — Cost of products sold $ 3,573 (3) — $ 3,449 — — Research, development and engineering $ 836 (2) — $ 767 (5) — Marketing and selling $ 205 — — $ 193 (1) — General and administrative $ 222 (1) — $ 214 (1) — Interest Rate Contracts: Interest expense $ 63 (3) — $ 60 (4) — $ (2) $ — $ (3) $ — Nine Months Ended July 28, 2024 July 30, 2023 Derivatives in Cash Flow Hedging Relationships Derivatives in Cash Flow Hedging Relationships Total Amount Presented in the Consolidated Condensed Statement of Operations in which the Effects of Cash Flow Hedges are Recorded Amount of Gain or (Loss) Amount of Gain (Loss) Excluded from Effectiveness Testing Total Amount Presented in the Consolidated Condensed Statement of Operations in which the Effects of Cash Flow Hedges are Recorded Amount of Gain or (Loss) Amount of Gain (Loss) Excluded from Effectiveness Testing (In millions) Foreign Exchange Contracts: Net sales $ 20,131 $ 21 $ (1) $ 19,794 $ 47 $ — Cost of products sold $ 10,569 (4) — $ 10,579 2 — Research, development and engineering $ 2,375 (6) — $ 2,313 (8) — Marketing and selling $ 621 (1) — $ 584 (1) — General and administrative $ 745 (1) — $ 635 (2) — Interest Rate Contracts: Interest expense $ 181 (9) — $ 180 (10) — $ — $ (1) $ 28 $ — Amount of Gain or (Loss) Three Months Ended Nine Months Ended Location of Gain or July 28, July 30, July 28, July 30, (In millions) Derivatives Not Designated as Hedging Instruments Foreign exchange contracts Interest and other income, net $ 2 $ 11 $ 20 $ (25) Total return swaps - deferred compensation Cost of products sold 1 2 5 3 Total return swaps - deferred compensation Operating expenses 16 15 55 29 Total return swaps - deferred compensation Interest and other income, net (4) (4) (11) (8) Total $ 15 $ 24 $ 69 $ (1) Credit Risk Contingent Features If our credit rating were to fall below investment grade, we would be in violation of credit risk contingent provisions of the derivative instruments discussed above, and certain counterparties to the derivative instruments could request immediate payment on derivative instruments in net liability positions. The aggregate fair value of all derivative instruments with credit-risk related contingent features that were in a net liability position was immaterial as of July 28, 2024. Entering into derivative contracts with banks exposes us to credit-related losses in the event of the banks’ nonperformance. However, our exposure is not considered significant.

Accounts Receivable, Net

Accounts Receivable, Net	9 Months Ended
	Jul. 28, 2024
Receivables [Abstract]
Accounts Receivable, Net	Accounts Receivable, Net We have agreements with various financial institutions to sell accounts receivable and discount promissory notes from selected customers. We sell our accounts receivable generally without recourse. From time to time, we also discount letters of credit issued by customers through various financial institutions. The discounting of letters of credit depends on many factors, including the willingness of financial institutions to discount the letters of credit and the cost of such arrangements. We sold $131 million and $395 million of account receivables during the three and nine months ended July 28, 2024, respectively. We sold $90 million and $619 million of account receivables during the three and nine months ended July 30, 2023, respectively. We did not discount letters of credit issued by customers or discount promissory notes during the three and nine months ended July 28, 2024 and July 30, 2023. Financing charges on the sale of receivables and discounting of letters of credit are included in interest expense in the accompanying Consolidated Condensed Statements of Operations and were not material for all periods presented. Accounts receivable are presented net of allowance for credit losses of $29 million as of July 28, 2024 and as of October 29, 2023. We sell our products principally to manufacturers within the semiconductor and display industries. While we believe that our allowance for credit losses is adequate and represents our best estimate as of July 28, 2024, we continue to closely monitor customer liquidity and industry and economic conditions, which may result in changes to our estimates.

Contract Balances and Performan

Contract Balances and Performance Obligations	9 Months Ended
	Jul. 28, 2024
Revenue from Contract with Customer [Abstract]
Contract Balances and Performance Obligations	Contract Balances and Performance Obligations Contract Assets and Liabilities Contract assets primarily result from receivables for goods transferred to customers where payment is conditional upon technical sign off and not just the passage of time. Contract liabilities consist of unsatisfied performance obligations related to advance payments received and billings in excess of revenue recognized. Our contract assets and liabilities are reported in a net position on a contract-by-contract basis at the end of each reporting period. Contract assets are generally classified as current and are included in Other Current Assets in the Consolidated Condensed Balance Sheets. Contract liabilities are classified as current or non-current based on the timing of when performance obligations will be satisfied and associated revenue is expected to be recognized. Contract balances at the end of each reporting period were as follows: July 28, 2024 October 29, 2023 (In millions) Contract assets $ 324 $ 274 Contract liabilities $ 2,742 $ 2,975 The increase in contract assets during the nine months ended July 28, 2024 was primarily due to an increase in unsatisfied performance obligations related to goods transferred to customers where payment was conditional upon technical sign off. During the nine months ended July 28, 2024, we recognized revenue of approximately $2.5 billion related to contract liabilities at October 29, 2023. Contract liabilities decreased during the nine months ended July 28, 2024 due to revenue recognized related to contract liabilities at October 29, 2023, partially offset by new billings for products and services for which there were unsatisfied performance obligations to customers and revenue had not yet been recognized as of July 28, 2024. There were no credit losses recognized on our accounts receivables and contract assets during both the nine months ended July 28, 2024 and July 30, 2023. Performance Obligations As of July 28, 2024, the amount of remaining unsatisfied performance obligations on contracts, primarily consisting of written purchase orders received from customers, with an original estimated duration of one year or more was approximately $4.2 billion, of which approximately 63% is expected to be recognized within 12 months and the remainder is expected to be recognized within the following 24 months thereafter. We have elected the available practical expedient to exclude the value of unsatisfied performance obligations for contracts with an original expected duration of one year or less.

Balance Sheet Detail

Balance Sheet Detail	9 Months Ended
	Jul. 28, 2024
Balance Sheet Detail [Abstract]
Balance Sheet Detail	Balance Sheet Detail July 28, October 29, (In millions) Inventories Customer service spares $ 1,727 $ 1,589 Raw materials 1,688 1,653 Work-in-process 945 997 Finished goods Deferred cost of sales 267 413 Evaluation inventory 487 423 Manufactured on-hand inventory 454 650 Total finished goods 1,208 1,486 Total inventories $ 5,568 $ 5,725 July 28, October 29, (In millions) Other Current Assets Prepaid income taxes and income taxes receivable $ 51 $ 412 Prepaid expenses and other 979 976 $ 1,030 $ 1,388 Useful Life July 28, October 29, (In years) (In millions) Property, Plant and Equipment, Net Land and improvements $ 436 $ 393 Buildings and improvements 3-30 2,314 2,194 Demonstration and manufacturing equipment 5-8 2,573 2,353 Furniture, fixtures and other equipment 3-5 806 762 Construction in progress 828 672 Gross property, plant and equipment 6,957 6,374 Accumulated depreciation (3,857) (3,651) $ 3,100 $ 2,723 July 28, October 29, (In millions) Deferred Income Taxes and Other Assets Non-current deferred income taxes $ 2,107 $ 1,729 Operating lease right-of-use assets 355 370 Finance lease right-of-use assets 91 108 Income tax receivables and other assets 348 345 $ 2,901 $ 2,552 July 28, October 29, (In millions) Accounts Payable and Accrued Expenses Accounts payable $ 1,470 $ 1,478 Compensation and employee benefits 995 1,024 Warranty 347 332 Dividends payable 330 267 Income taxes payable 365 282 Other accrued taxes 74 65 Interest payable 59 38 Operating lease liabilities, current 86 84 Finance lease liabilities, current 89 102 Other 572 625 $ 4,387 $ 4,297 July 28, October 29, (In millions) Other Liabilities Defined and postretirement benefit plans $ 121 $ 126 Operating lease liabilities, non-current 239 252 Other 390 336 $ 750 $ 714 Government Assistance We receive government assistance from various domestic and foreign governments in the form of cash grants or refundable tax credits. These arrangements incentivize capital investments and research and development activities. Government incentives generally contain conditions that must be met in order for the assistance to be earned. We recognize the incentives when there is reasonable assurance that we will comply with all conditions specified in the incentive arrangement and the incentive will be received. We record capital expenditure related incentives as an offset to the associated property, plant and equipment, net within our Consolidated Condensed Balance Sheets and recognize a reduction to depreciation expense over the useful life of the corresponding acquired asset. We record incentives related to operating activities as a reduction to expense in the same line item on the Consolidated Condensed Statements of Operations as the expenditure for which the grant is intended to compensate. Capital expenditure related incentives reduced gross property, plant and equipment, net

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Jul. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill and intangible assets with indefinite useful lives are not amortized but are reviewed for impairment annually during the fourth quarter of each fiscal year and whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Goodwill As of July 28, 2024, our reporting units include Semiconductor Products Group and Imaging and Process Control Group, Applied Global Services, Display and Adjacent Markets and other reporting units recorded under Corporate and Other. The Semiconductor Products Group and Imaging and Process Control Group combine to form the Semiconductor Systems reporting segment. Details of goodwill as of July 28, 2024 and October 29, 2023 were as follows: July 28, October 29, (In millions) Goodwill by reportable segment Semiconductor Systems $ 2,460 $ 2,460 Applied Global Services 1,032 1,032 Display and Adjacent Markets 199 199 Corporate and Other 41 41 $ 3,732 $ 3,732 Intangible Assets Details of intangible assets other than goodwill were as follows: July 28, 2024 October 29, 2023 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount (In millions) Intangible assets with finite lives: Semiconductor Systems $ 2,001 $ (1,744) $ 257 $ 2,001 $ (1,714) $ 287 Applied Global Services 79 (79) — 79 (78) 1 Display and Adjacent Markets 194 (194) — 194 (194) — Corporate and Other 37 (32) 5 36 (30) 6 Total intangible assets with finite lives $ 2,311 $ (2,049) $ 262 $ 2,310 $ (2,016) $ 294 Amortization expense of intangible assets was $11 million and $33 million during the three and nine months ended July 28, 2024, respectively. Amortization expense of intangible assets was $11 million and $34 million during the three and nine months ended July 30, 2023, respectively. As of July 28, 2024, future estimated amortization expense of intangible assets with finite lives is expected to be as follows: Amortization Expense (In millions) 2024 (remaining 3 months) $ 10 2025 41 2026 40 2027 26 2028 23 Thereafter 122 Total $ 262

Borrowing Facilities and Debt

Borrowing Facilities and Debt	9 Months Ended
	Jul. 28, 2024
Debt Disclosure [Abstract]
Borrowing Facilities and Debt	Borrowing Facilities and Debt Revolving Credit Facilities In February 2020, we entered into a five-year $1.5 billion committed unsecured revolving credit agreement (Revolving Credit Agreement) with a group of banks. The Revolving Credit Agreement includes a provision under which we may request an increase in the amount of the facility of up to $500 million for a total commitment of no more than $2.0 billion, subject to the receipt of commitments from one or more lenders for any such increase and other customary conditions. The Revolving Credit Agreement is scheduled to expire in February 2026, unless extended as permitted under the Revolving Credit Agreement. The Revolving Credit Agreement provides for borrowings that bear interest for each advance at one of two rates selected by us, plus an applicable margin, which varies according to our public debt credit ratings. No amounts were outstanding under the Revolving Credit Agreement as of July 28, 2024 and October 29, 2023. In addition, we have revolving credit facilities with Japanese banks pursuant to which we may borrow up to approximately $52 million in aggregate at any time. Our ability to borrow under these facilities is subject to bank approval at the time of the borrowing request, and any advances will be at rates indexed to the banks’ prime reference rate denominated in Japanese yen. As of July 28, 2024 and October 29, 2023, no amounts were outstanding under these revolving credit facilities. Short-term Commercial Paper We have a short-term commercial paper program under which we may issue unsecured commercial paper notes of up to a total amount of $1.5 billion. The proceeds from the issuances of commercial paper are used for general corporate purposes. As of July 28, 2024, we had commercial paper notes outstanding with an aggregate principal amount of $100 million, which were recorded as short-term debt with a weighted-average interest rate of 5.34% and maturities of 98 days, and as of October 29, 2023, we had $100 million of commercial paper notes outstanding and recorded as short-term debt with a weighted-average interest rate of 5.39% and maturities of 90 days. Senior Unsecured Notes In June 2024, we issued $700 million aggregate principal amount of 4.800% senior unsecured notes due 2029 in a registered public offering. The proceeds from the issuance of the senior unsecured notes are intended for general corporate purposes. Debt outstanding as of July 28, 2024 and October 29, 2023 was as follows: Principal Amount July 28, October 29, Effective Interest (In millions) Long-term debt: 3.900% Senior Notes Due 2025 $ 700 $ 700 3.944% April 1, October 1 3.300% Senior Notes Due 2027 1,200 1,200 3.342% April 1, October 1 4.800% Senior Notes Due 2029 700 — 4.844% June 15, December 15 1.750% Senior Notes Due 2030 750 750 1.792% June 1, December 1 5.100% Senior Notes Due 2035 500 500 5.127% April 1, October 1 5.850% Senior Notes Due 2041 600 600 5.879% June 15, December 15 4.350% Senior Notes Due 2047 1,000 1,000 4.361% April 1, October 1 2.750% Senior Notes Due 2050 750 750 2.773% June 1, December 1 6,200 5,500 Total unamortized discount (11) (11) Total unamortized debt issuance costs (31) (28) Total long-term debt $ 6,158 $ 5,461

Leases

Leases	9 Months Ended
	Jul. 28, 2024
Leases [Abstract]
Leases	Leases A contract contains a lease when we have the right to control the use of an identified asset for a period of time in exchange for consideration. A majority of our lease arrangements are operating leases. We also have certain leases that qualify as finance leases. We lease certain facilities, vehicles and equipment under non-cancelable operating leases, many of which include options to renew. Options that are reasonably certain to be exercised are included in the calculation of the right-of-use asset and lease liability. Our finance leases are those that contain a purchase option which we are reasonably certain to exercise at the end of the lease term. Our leases do not contain residual value guarantees or significant restrictions that impact the accounting for leases. As implicit rates are not available for the leases, we use the incremental borrowing rate as of the lease commencement date in order to measure the right-of-use asset and liability. Operating lease expense is generally recognized on a straight-line basis over the lease term. Finance lease expense is generally recognized on a straight-line basis over the life of the underlying leased asset. We elected the practical expedient to account for lease and non-lease components as a single lease component for all leases. For leases with a term of one year or less, we elected not to record a right-of-use asset or lease liability and to account for the associated lease payments as they become due. The components of lease expense and supplemental information were as follows: Three Months Ended Nine Months Ended July 28, July 30, July 28, July 30, (In millions, except percentages) Operating lease cost $ 27 $ 25 $ 81 $ 78 Finance lease cost: Amortization of right-of-use assets $ 1 $ — $ 2 $ 1 Interest on lease liabilities $ 1 $ 1 $ 3 $ 2 Weighted-average remaining lease term (in years) - operating leases 5.5 5.8 Weighted-average remaining lease term (in years) - finance leases 0.2 1.1 Weighted-average discount rate - operating leases 3.2% 2.9% Weighted-average discount rate - finance leases 4.6% 4.6% Supplemental cash flow information related to leases are as follows: Nine Months Ended July 28, July 30, (In millions) Operating cash flows paid for operating leases $ 80 $ 89 Operating cash flows paid for finance leases $ 3 $ 2 Financing cash flows paid for finance leases $ 12 $ 8 Right-of-use assets obtained in exchange for operating lease liabilities $ 73 $ 83 Right-of-use assets obtained in exchange for finance lease liabilities $ — $ 109 As of July 28, 2024, the maturities of lease liabilities are as follows: Operating Leases Finance Leases Fiscal (In millions) 2024 (remaining 3 months) $ 21 $ 90 2025 96 — 2026 60 — 2027 47 — 2028 39 — Thereafter 93 — Total lease payments $ 356 $ 90 Less imputed interest (31) (1) Total $ 325 $ 89
Leases	Leases A contract contains a lease when we have the right to control the use of an identified asset for a period of time in exchange for consideration. A majority of our lease arrangements are operating leases. We also have certain leases that qualify as finance leases. We lease certain facilities, vehicles and equipment under non-cancelable operating leases, many of which include options to renew. Options that are reasonably certain to be exercised are included in the calculation of the right-of-use asset and lease liability. Our finance leases are those that contain a purchase option which we are reasonably certain to exercise at the end of the lease term. Our leases do not contain residual value guarantees or significant restrictions that impact the accounting for leases. As implicit rates are not available for the leases, we use the incremental borrowing rate as of the lease commencement date in order to measure the right-of-use asset and liability. Operating lease expense is generally recognized on a straight-line basis over the lease term. Finance lease expense is generally recognized on a straight-line basis over the life of the underlying leased asset. We elected the practical expedient to account for lease and non-lease components as a single lease component for all leases. For leases with a term of one year or less, we elected not to record a right-of-use asset or lease liability and to account for the associated lease payments as they become due. The components of lease expense and supplemental information were as follows: Three Months Ended Nine Months Ended July 28, July 30, July 28, July 30, (In millions, except percentages) Operating lease cost $ 27 $ 25 $ 81 $ 78 Finance lease cost: Amortization of right-of-use assets $ 1 $ — $ 2 $ 1 Interest on lease liabilities $ 1 $ 1 $ 3 $ 2 Weighted-average remaining lease term (in years) - operating leases 5.5 5.8 Weighted-average remaining lease term (in years) - finance leases 0.2 1.1 Weighted-average discount rate - operating leases 3.2% 2.9% Weighted-average discount rate - finance leases 4.6% 4.6% Supplemental cash flow information related to leases are as follows: Nine Months Ended July 28, July 30, (In millions) Operating cash flows paid for operating leases $ 80 $ 89 Operating cash flows paid for finance leases $ 3 $ 2 Financing cash flows paid for finance leases $ 12 $ 8 Right-of-use assets obtained in exchange for operating lease liabilities $ 73 $ 83 Right-of-use assets obtained in exchange for finance lease liabilities $ — $ 109 As of July 28, 2024, the maturities of lease liabilities are as follows: Operating Leases Finance Leases Fiscal (In millions) 2024 (remaining 3 months) $ 21 $ 90 2025 96 — 2026 60 — 2027 47 — 2028 39 — Thereafter 93 — Total lease payments $ 356 $ 90 Less imputed interest (31) (1) Total $ 325 $ 89

Stockholders' Equity, Comprehen

Stockholders' Equity, Comprehensive Income and Share-Based Compensation	9 Months Ended
	Jul. 28, 2024
Equity [Abstract]
Stockholders' Equity, Comprehensive Income and Share-Based Compensation	Stockholders’ Equity, Comprehensive Income and Share-Based Compensation Accumulated Other Comprehensive Income (Loss) Changes in the components of accumulated other comprehensive income (loss) (AOCI), net of tax, were as follows: Unrealized Gain (Loss) on Investments, Net Unrealized Gain (Loss) on Derivative Instruments Qualifying as Cash Flow Hedges Defined and Postretirement Benefit Plans Cumulative Translation Adjustments Total (in millions) Balance as of October 29, 2023 $ (50) $ (118) $ (62) $ 13 $ (217) Other comprehensive income (loss) before reclassifications 27 44 — — 71 Amounts reclassified out of AOCI 9 — (9) — — Other comprehensive income (loss), net of tax 36 44 (9) — 71 Balance as of July 28, 2024 $ (14) $ (74) $ (71) $ 13 $ (146) Unrealized Gain (Loss) on Investments, Net Unrealized Gain (Loss) on Derivative Instruments Qualifying as Cash Flow Hedges Defined and Postretirement Benefit Plans Cumulative Translation Adjustments Total (in millions) Balance as of October 30, 2022 $ (75) $ (52) $ (88) $ 13 $ (202) Other comprehensive income (loss) before reclassifications 16 (25) — — (9) Amounts reclassified out of AOCI 9 (21) — — (12) Other comprehensive income (loss), net of tax 25 (46) — — (21) Balance as of July 30, 2023 $ (50) $ (98) $ (88) $ 13 $ (223) The tax effects on net income of amounts reclassified from AOCI for the three and nine months ended July 28, 2024 and July 30, 2023 were not material. Stock Repurchase Program In March 2023, our Board of Directors approved a common stock repurchase program authorizing $10.0 billion in repurchases, which supplemented the previously existing $6.0 billion authorization approved in March 2022. As of July 28, 2024, approximately $10.3 billion remained available for future stock repurchases under the repurchase program. The following table summarizes our stock repurchases, including and excluding excise tax, for the three and nine months ended July 28, 2024 and July 30, 2023: Three Months Ended Nine Months Ended July 28, July 30, July 28, July 30, (in millions, except per share amount) Shares of common stock repurchased 4 4 13 13 Cost of stock repurchased (including excise tax) * $ 868 $ 443 $ 2,398 $ 1,497 Average price paid per share (including excise tax) * $ 222.82 $ 131.09 $ 189.90 $ 117.35 Cost of stock repurchased (excluding excise tax) $ 861 $ 439 $ 2,381 $ 1,489 Average price paid per share (excluding excise tax) $ 221.27 $ 129.86 $ 188.60 $ 116.70 (*) Stock repurchase amounts include the 1% surcharge on stock repurchases under the Inflation Reduction Act’s excise tax. This excise tax is recorded in equity and reduces the amount available under the repurchase program, as applicable. We record treasury stock purchases under the cost method using the first-in, first-out (FIFO) method. Upon reissuance of treasury stock, amounts in excess of the acquisition cost are credited to additional paid in capital. If we reissue treasury stock at an amount below our acquisition cost and additional paid in capital associated with prior treasury stock transactions is insufficient to cover the difference between the acquisition cost and the reissue price, this difference is recorded against retained earnings. Dividends In June 2024, March 2024 and December 2023, our Board of Directors declared quarterly cash dividends in the amount of $0.40, $0.40 and $0.32 per share, respectively. The dividend declared in June 2024 is payable in September 2024. Dividends paid during the nine months ended July 28, 2024 and July 30, 2023 totaled $863 million and $707 million, respectively. We currently anticipate that cash dividends will continue to be paid on a quarterly basis, although the declaration of any future cash dividend is at the discretion of the Board of Directors and will depend on our financial condition, results of operations, capital requirements, business conditions and other factors, as well as a determination by the Board of Directors that cash dividends are in the best interests of our stockholders. Share-Based Compensation We have a stockholder-approved equity plan, the Employee Stock Incentive Plan (ESIP), which permits grants to employees of share-based awards, including stock options, stock appreciation rights, restricted stock, restricted stock units, performance share units and performance units. In addition, the plan provides for the automatic grant of restricted stock units to non-employee directors and permits the grant of share-based awards to non-employee directors and consultants. Share-based awards made under the plan may be subject to accelerated vesting under certain circumstances in the event of a change in control. In addition, we have an Omnibus Employees’ Stock Purchase Plan (ESPP), which enables eligible employees to purchase our common stock. During the three and nine months ended July 28, 2024 and July 30, 2023, we recognized share-based compensation expense related to equity awards and ESPP shares. The effect of share-based compensation on the results of operations was as follows: Three Months Ended Nine Months Ended July 28, July 30, July 28, July 30, (In millions) Cost of products sold $ 33 $ 42 $ 98 $ 138 Research, development and engineering 53 42 163 137 Marketing and selling 17 13 53 42 General and administrative 29 17 122 58 Total share-based compensation $ 132 $ 114 $ 436 $ 375 The cost associated with share-based awards is typically recognized over the awards’ service period for the entire award on a straight-line basis, adjusting for estimated forfeitures. However, in the case of share-based awards granted to certain members of senior management that allow for partial accelerated vesting in the event of a qualifying retirement based on age and years of service, the compensation expense is recognized once the individual meets the conditions for a qualifying retirement. We calculate estimated forfeiture rate on an annual basis, based on historical forfeiture activities. The cost associated with performance-based equity awards, which include performance and/or market goals, is recognized for each tranche over the service period. The cost of the portion of performance-based equity awards subject to performance goals is recognized based on an assessment of the likelihood that the applicable performance goals will be achieved, and the cost of the portion of performance-based equity awards subject to market goals is recognized based on the assumption of 100% achievement of the goal. As of July 28, 2024, we had $977 million in total unrecognized compensation expense, net of estimated forfeitures, related to grants of share-based awards under the ESIP and shares issued under the ESPP, which will be recognized over a weighted average period of 2.7 years. As of July 28, 2024, there were 21 million shares available for grant of share-based awards under the ESIP, and an additional 11 million shares available for issuance under the ESPP. Restricted Stock Units, Restricted Stock, Performance Share Units and Performance Units A summary of the changes in restricted stock units, restricted stock, performance share units and performance units outstanding under our equity compensation plans during the nine months ended July 28, 2024 is presented below: Shares Weighted Average (In millions, except per share amounts) Outstanding as of October 29, 2023 12 $ 106.24 Granted 4 $ 148.07 Vested (4) $ 97.11 Canceled (1) $ 119.91 Outstanding as of July 28, 2024 11 $ 127.04 As of July 28, 2024, 0.7 million additional performance-based awards could be earned based upon achievement of certain levels of specified performance and/or market goals. During the first half of fiscal 2024, certain members of senior management were granted awards that are subject to the achievement of targeted levels of adjusted operating margin and targeted levels of total shareholder return (TSR) relative to the TSR of the companies in the Standard & Poor's 500 Index. Each of these two metrics will be weighted 50% and will be measured over a three-year period. The number of shares that may vest in full after three years ranges from 0% to 200% of the target amount. The awards become eligible to vest only if the goals are achieved and will vest only if the grantee remains employed by us through each applicable vesting date, subject to a qualifying retirement based on age and years of service. The awards provide for a partial vesting based on actual performance at the conclusion of the three-year performance period in the event of a qualifying retirement. The fair value of the portion of the awards subject to targeted levels of relative TSR is estimated on the date of grant using a Monte Carlo simulation model. Compensation expense is recognized based upon the assumption of 100% achievement of the TSR goal and will not be reversed even if the threshold level of TSR is never achieved, and is reflected over the service period and reduced for estimated forfeitures. The fair value of the portion of the awards subject to targeted levels of adjusted operating margin is estimated on the date of grant. If the performance goals are not met as of the end of the performance period, no compensation expense is recognized and any previously recognized compensation expense is reversed. The expected cost is based on the portion of the awards that is probable to vest and is reflected over the service period and reduced for estimated forfeitures. Employee Stock Purchase Plans Under the ESPP, substantially all employees may purchase our common stock through payroll deductions at a price equal to 85 percent of the lower of the fair market value of our common stock at the beginning or end of each 6-month purchase period, subject to certain limits. Our purchasing cycles begin in March and September of each of fiscal year. We issued a total of 1 million shares in each of the nine months ended July 28, 2024 and July 30, 2023. Compensation expense is calculated using the fair value of the employees’ purchase rights under the Black-Scholes model. Underlying assumptions used in the model are outlined in the following table: Nine Months Ended July 28, July 30, Dividend yield 0.76% 1.09% Expected volatility 35.6% 43.3% Risk-free interest rate 5.27% 5.14% Expected life (in years) 0.5 0.5 Weighted average estimated fair value $53.98 $32.47

Income Taxes

Income Taxes	9 Months Ended
	Jul. 28, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Our provision for income taxes and effective tax rate are affected by the geographical composition of pre-tax income which includes jurisdictions with differing tax rates, conditional reduced tax rates and other income tax incentives. It is also affected by events that vary from period to period, such as changes in income tax laws and the resolution of prior years’ income tax filings. Our effective tax rates for the third quarter of fiscal 2024 and 2023 were 13.0 percent and 13.6 percent, respectively. The effective tax rate for the third quarter of fiscal 2024 was lower than the same period in the prior fiscal year primarily due to larger excess tax benefits from share-based compensation in fiscal 2024. Our effective tax rates for the first nine months of fiscal 2024 and 2023 were 13.0 percent and 12.5 percent, respectively. The effective tax rate for the first nine months of fiscal 2024 was higher than the same period in the prior fiscal year primarily due to lower tax credits in fiscal 2024, partially offset by larger excess tax benefits from share-based compensation in fiscal 2024.

Warranty, Guarantees, Commitmen

Warranty, Guarantees, Commitments and Contingencies	9 Months Ended
	Jul. 28, 2024
Commitments and Contingencies Disclosure [Abstract]
Warranty, Guarantees, Commitments and Contingencies	Warranty, Guarantees, Commitments and Contingencies Warranty Changes in the warranty reserves are presented below: Three Months Ended Nine Months Ended July 28 July 30 July 28 July 30 (In millions) Beginning balance $ 346 $ 310 $ 332 $ 286 Provisions for warranty 62 62 181 186 Changes in reserves related to preexisting warranty (8) (2) (14) — Consumption of reserves (53) (57) (152) (159) Ending balance $ 347 $ 313 $ 347 $ 313 Our products are generally sold with a warranty for a 12-month period following installation. The provision for the estimated cost of warranty is recorded when revenue is recognized. Parts and labor are covered under the terms of the warranty agreement. The warranty provision is based on historical experience by product, configuration and geographic region. Quarterly warranty consumption is generally associated with sales that occurred during the preceding four quarters, and quarterly warranty provisions are generally related to the current quarter’s sales. Guarantees In the ordinary course of business, we provide standby letters of credit or other guarantee instruments to third parties as required for certain transactions initiated by either us or our subsidiaries. As of July 28, 2024, the maximum potential amount of future payments that we could be required to make under these guarantee agreements was approximately $308 million. We have not recorded any liability in connection with these guarantee agreements beyond that required to appropriately account for the underlying transaction being guaranteed. We do not believe, based on historical experience and information currently available, that it is probable that any amounts will be required to be paid under these guarantee agreements. We also have agreements with various banks to facilitate subsidiary banking operations worldwide, including overdraft arrangements, issuance of bank guarantees, and letters of credit. As of July 28, 2024, we have provided parent guarantees to banks for approximately $292 million to cover these arrangements. Legal Matters From time to time, we receive notification from third parties, including customers and suppliers, seeking indemnification, litigation support, payment of money or other actions by us in connection with claims made against them. In addition, from time to time, we receive notification from third parties claiming that we may be or are infringing or misusing their intellectual property or other rights. We also are subject to various legal proceedings, government investigations or inquiries, and claims, both asserted and unasserted, that arise in the ordinary course of business. These matters are subject to uncertainties, and we cannot predict the outcome of these matters, or governmental inquiries or proceedings that may occur. Although the outcome of the above-described matters, claims and proceedings cannot be predicted with certainty, we do not believe at this time that any of the above-described matters will have a material effect on our consolidated financial condition or results of operations. Since 2022, we have received multiple subpoenas from government authorities requesting information relating to certain China customer shipments and export controls compliance, including from the U.S. Department of Justice, the U.S. Commerce Department Bureau of Industry and Security, and the U.S. Securities and Exchange Commission. We also have received subpoenas from the U.S. Department of Justice requesting information related to certain federal award applications and information submitted to the federal government. We are cooperating fully with the U.S. government in these matters. We have continued to receive related subpoenas, as well as requests for information, and may in the future receive additional related subpoenas and requests for information from such or other government authorities. Any such matters are subject to uncertainties, and we cannot predict the outcome, nor reasonably estimate a range of loss or penalties, if any, relating to these matters.

Industry Segment Operations

Industry Segment Operations	9 Months Ended
	Jul. 28, 2024
Segment Reporting [Abstract]
Industry Segment Operations	Industry Segment Operations Our three reportable segments are: Semiconductor Systems, Applied Global Services, and Display and Adjacent Markets. As defined under the accounting literature, our chief operating decision-maker has been identified as the President and Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the entire company. Segment information is presented based upon our management organization structure as of July 28, 2024 and the distinctive nature of each segment. Future changes to this internal financial structure may result in changes to our reportable segments. The Semiconductor Systems reportable segment includes semiconductor capital equipment for etch, rapid thermal processing, deposition, chemical mechanical planarization, metrology and inspection, wafer packaging, and ion implantation. The Applied Global Services segment provides integrated solutions to optimize equipment and fab performance and productivity, including spares, upgrades, services, 200mm generation equipment and factory automation software for semiconductor, display and other products. The Display and Adjacent Markets segment includes products for manufacturing liquid crystal displays (LCDs), organic light-emitting diodes (OLEDs), equipment upgrades and other display technologies for TVs, monitors, laptops, personal computers, smart phones, other consumer-oriented devices and solar energy cells. Each operating segment is separately managed and has separate financial results that are reviewed by our chief operating decision-maker. Each reportable segment contains closely related products that are unique to the particular segment. Segment operating income is determined based upon internal performance measures used by our chief operating decision-maker. The chief operating decision-maker does not evaluate operating segments using total asset information. We derive the segment results directly from our internal management reporting system. Effective in the first quarter of fiscal 2024, management began including share-based compensation expense in the evaluation of reportable segments' performance. Prior-year numbers have been recast to conform to the current-year presentation. The accounting policies we use to derive reportable segment results are substantially the same as those used for external reporting purposes. Management measures the performance of each reportable segment based upon several metrics including orders, net revenue and operating income. Management uses these results to evaluate the performance of, and to assign resources to, each of the reportable segments. The Corporate and Other category includes revenues from products, as well as costs of products sold, for fabricating solar photovoltaic cells and modules, and certain operating expenses that are not allocated to our reportable segments and are managed separately at the corporate level. These operating expenses include costs related to certain management, finance, legal, human resources, and research, development and engineering functions provided at the corporate level and unabsorbed information technology and occupancy. In addition, we do not allocate to our reportable segments restructuring, severance and asset impairment charges and any associated adjustments related to restructuring actions, unless these actions pertain to a specific reportable segment. Segment operating income also excludes interest income/expense and other financial charges and income taxes. Management does not consider the unallocated costs in measuring the performance of the reportable segments. Net revenue and operating income (loss) for each reportable segment were as follows: Three Months Ended Nine Months Ended Net Revenue Operating Net Revenue Operating (In millions) July 28, 2024: Semiconductor Systems $ 4,924 $ 1,712 $ 14,734 $ 5,157 Applied Global Services 1,580 467 4,586 1,320 Display and Adjacent Markets 251 16 674 46 Corporate and Other 23 (253) 137 (702) Total $ 6,778 $ 1,942 $ 20,131 $ 5,821 July 30, 2023: Semiconductor Systems $ 4,676 $ 1,568 $ 14,815 $ 5,138 Applied Global Services 1,464 399 4,261 1,128 Display and Adjacent Markets 235 32 570 51 Corporate and Other 50 (197) 148 (634) Total $ 6,425 $ 1,802 $ 19,794 $ 5,683 Semiconductor Systems and Display and Adjacent Markets revenues are recognized at a point in time. Applied Global Services revenue is recognized at a point in time for tangible goods such as spare parts and equipment, and over time for service agreements. The majority of revenue recognized over time is recognized within 12 months of the contract inception. Net revenue by geographic region, determined by the location of customers’ facilities to which products were shipped to, were as follows: Three Months Ended Nine Months Ended July 28, July 30, Change July 28, July 30, Change (In millions, except percentages) China $ 2,153 32 % $ 1,734 27 % 24 % $ 7,981 40 % $ 4,284 22 % 86 % Korea 1,102 16 % 988 15 % 12 % 3,321 16 % 3,864 19 % (14) % Taiwan 1,148 17 % 1,345 21 % (15) % 2,726 14 % 4,748 24 % (43) % Japan 555 8 % 478 8 % 16 % 1,573 8 % 1,394 7 % 13 % Southeast Asia 428 6 % 180 3 % 138 % 827 4 % 590 3 % 40 % Asia Pacific 5,386 79 % 4,725 74 % 14 % 16,428 82 % 14,880 75 % 10 % United States 1,053 16 % 1,039 16 % 1 % 2,665 13 % 3,203 16 % (17) % Europe 339 5 % 661 10 % (49) % 1,038 5 % 1,711 9 % (39) % Total $ 6,778 100 % $ 6,425 100 % 5 % $ 20,131 100 % $ 19,794 100 % 2 % Net revenue for Semiconductor Systems by end use application for the periods indicated were as follows: Three Months Ended Nine Months Ended July 28, July 30, July 28, July 30, Foundry, logic and other 72 % 79 % 66 % 80 % Dynamic random-access memory (DRAM) 24 % 17 % 30 % 14 % Flash memory 4 % 4 % 4 % 6 % 100 % 100 % 100 % 100 % The reconciling items included in Corporate and Other were as follows: Three Months Ended Nine Months Ended July 28, July 30, July 28, July 30, (In millions) Unallocated net revenue $ 23 $ 50 $ 137 $ 148 Unallocated cost of products sold and expenses (276) (247) (839) (782) Total $ (253) $ (197) $ (702) $ (634) The following customer accounted for at least 10 percent of our net revenue for the nine months ended July 28, 2024, and sales to this customer included products and services from multiple reportable segments. Percentage of Net Revenue Samsung Electronics Co., Ltd. 12 %

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023
Pay vs Performance Disclosure
Net income	$ 1,705	$ 1,560	$ 5,446	$ 4,852

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jul. 28, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Basis of Presentation (Policies

Basis of Presentation (Policies)	9 Months Ended
	Jul. 28, 2024
Accounting Policies [Abstract]
Basis of Presentation	In the opinion of our management, the unaudited interim consolidated condensed financial statements of Applied Materials, Inc. and its subsidiaries (we, us, and our) included herein have been prepared on a basis consistent with the October 29, 2023 audited consolidated financial statements and include all material adjustments, consisting of normal recurring adjustments, necessary to fairly state the information set forth therein. These unaudited interim consolidated condensed financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended October 29, 2023 (2023 Form 10-K). The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make judgments, estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ materially from those estimates. Our results of operations for the three and nine months ended July 28, 2024 are not necessarily indicative of future operating results. Our fiscal year ends on the last Sunday in October of each year. Fiscal 2024 and 2023 contain 52 weeks each and the first nine months of fiscal 2024 and 2023 each contained 39 weeks. Certain prior-year amounts have been reclassified to conform to current-year presentation.
Use of Estimates	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make judgments, estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, we evaluate our estimates, including those related to standalone selling price (SSP) related to revenue recognition, accounts receivable and sales allowances, fair values of financial instruments, inventories, intangible assets and goodwill, useful lives of intangible assets and property, plant and equipment, fair values of share-based awards, warranty, and income taxes, among others. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.
Property, Plant and Equipment	Property, plant and equipment is stated at cost. Depreciation is provided over the estimated useful lives of the assets using the straight-line method. In connection with our periodic review of estimated useful lives of the property, plant, and equipment effective as of the beginning of fiscal 2024, we have increased the estimated useful lives of certain assets. The updated estimated useful lives for financial reporting purposes are as follows: buildings and improvements, 3 to 30 years with certain buildings and improvements’ useful lives increased by 5 years; demonstration and manufacturing equipment increased to between 5 to 8 years. The estimated useful lives for the remaining asset categories remained unchanged from fiscal 2023.
Recent Accounting Pronouncements	Accounting Standards Adopted Contract Assets and Contract Liabilities from Revenue Contracts with Customers in a Business Combination. In October 2021, the Financial Accounting Standards Board (FASB) issued an accounting standard update to improve the accounting for contract assets and contract liabilities from revenue contracts with customers in a business combination (Topic 805). This amendment improves comparability for both the recognition and measurement of acquired revenue contracts with customers at the date of and after a business combination. We adopted this authoritative guidance in the first quarter of fiscal 2024 and the impact of the adoption depends on the facts and circumstances of future acquisitions. Accounting Standards Not Yet Adopted Improvements to Income Tax Disclosures . In December 2023, the FASB issued an accounting standard update to improve income tax disclosures (Topic 740). The standard prescribes specific categories for the components of the effective tax rate reconciliation, requires disclosure of income taxes paid by jurisdiction, and modifies other income tax-related disclosures. This authoritative guidance will be effective for us beginning with our annual reporting for fiscal year 2026, with early adoption permitted. We are evaluating the effect of this new guidance on our consolidated financial statements and related disclosures. Improvements to Reportable Segment Disclosures . In November 2023, the FASB issued an accounting standard update to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses (Topic 280). The standard requires interim and annual disclosure of significant segment expenses that are regularly provided to the chief operating decision-maker (CODM) and included within the reported measure of a segment’s profit or loss, requires interim disclosures about a reportable segment’s profit or loss and assets that are currently required annually, requires disclosure of the position and title of the CODM, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss and contains other disclosure requirements. This authoritative guidance will be effective for us in fiscal 2025 for annual periods and in the first quarter of fiscal 2026 for interim periods, with early adoption permitted. We are evaluating the effect of this new guidance on our consolidated financial statements and related disclosures. Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. In June 2022, the FASB issued an accounting standard update which clarifies how the fair value of equity securities subject to contractual sale restrictions is determined (Topic 820). The amendment clarifies that a contractual sale restriction should not be considered in measuring fair value. It also requires certain qualitative and quantitative disclosures related to equity securities subject to contractual sale restrictions. This authoritative guidance will be effective for us in the first quarter of fiscal 2025, with early adoption permitted. The adoption of this guidance is not expected to have a significant impact on our consolidated financial statements.
Fair Value Measurements	Our financial assets are measured and recorded at fair value on a recurring basis, except for equity investments in privately held companies. These equity investments are generally accounted for under the measurement alternative, defined as cost, less impairments, adjusted for subsequent observable price changes and are periodically assessed for impairment when events or circumstances indicate that a decline in value may have occurred. Our nonfinancial assets, such as goodwill, intangible assets, and property, plant and equipment, are recorded at cost and are assessed for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Fair Value Hierarchy We use the following fair value hierarchy, which prioritizes the inputs to valuation techniques used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: • Level 1 — Quoted prices in active markets for identical assets or liabilities; • Level 2 — Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and • Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Our investments consist primarily of debt securities that are classified as available-for-sale and recorded at their fair values. In determining the fair value of investments, we use pricing information from pricing services that value securities based on quoted market prices and models that utilize observable market inputs. In the event a fair value estimate is unavailable from a pricing service, we generally obtain non-binding price quotes from brokers. In addition, to validate pricing information obtained from pricing services, we periodically perform supplemental analysis on a sample of securities. We review any significant unanticipated differences identified through this analysis to determine the appropriate fair value. As of July 28, 2024, substantially all of our available-for-sale, short-term and long-term investments were recognized at fair value that was determined based upon observable inputs or quoted prices. Our equity investments with readily determinable values consist of publicly traded equity securities. These investments are measured at fair value using quoted prices for identical assets in an active market and the changes in fair value of these equity investments are recognized in the consolidated statements of operations.
Assets and Liabilities without Readily Determinable Values Measured on a Non-recurring Basis	Assets and Liabilities without Readily Determinable Values Measured on a Non-recurring Basis Our equity investments without readily determinable values consist of equity investments in privately held companies. We elected the measurement alternative, defined as cost, less impairments, adjusted for subsequent observable price changes on a prospective basis for certain equity investments without readily determinable fair values and are required to account for any subsequent observable changes in fair value within the statements of operations. These investments are classified as Level 3 within the fair value hierarchy and periodically assessed for impairment when an event or circumstance indicates that a decline in value may have occurred. Impairment losses on equity investments in privately held companies were not material during the three and nine months ended July 28, 2024. Impairment losses on equity investments in privately held companies were not material during the three months ended July 30, 2023 and were $119 million during the nine months ended July 30, 2023. These impairment losses are included in interest and other income (expense), net in the Consolidated Condensed Statement of Operations.
Derivative Financial Instruments	We do not use derivative financial instruments for trading or speculative purposes. Derivative instruments and hedging activities, including foreign exchange and interest rate contracts, are recognized on the balance sheet at fair value. Changes in the fair value of derivatives that do not qualify for hedge accounting treatment are recognized currently in earnings. All of our derivative financial instruments are recorded at their fair value in other current assets or in accounts payable and accrued expenses. Foreign currency forward contracts are generally used to hedge certain foreign currency denominated assets or liabilities. Accordingly, changes in the fair value of these hedges are recorded in earnings to offset the changes in the fair value of the assets or liabilities being hedged.
Contract Assets and Liabilities	Contract assets primarily result from receivables for goods transferred to customers where payment is conditional upon technical sign off and not just the passage of time. Contract liabilities consist of unsatisfied performance obligations related to advance payments received and billings in excess of revenue recognized. Our contract assets and liabilities are reported in a net position on a contract-by-contract basis at the end of each reporting period. Contract assets are generally classified as current and are included in Other Current Assets in the Consolidated Condensed Balance Sheets. Contract liabilities are classified as current or non-current based on the timing of when performance obligations will be satisfied and associated revenue is expected to be recognized.
Government Assistance	We receive government assistance from various domestic and foreign governments in the form of cash grants or refundable tax credits. These arrangements incentivize capital investments and research and development activities. Government incentives generally contain conditions that must be met in order for the assistance to be earned. We recognize the incentives when there is reasonable assurance that we will comply with all conditions specified in the incentive arrangement and the incentive will be received.
Goodwill and Intangible Assets	Goodwill and intangible assets with indefinite useful lives are not amortized but are reviewed for impairment annually during the fourth quarter of each fiscal year and whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Goodwill As of July 28, 2024, our reporting units include Semiconductor Products Group and Imaging and Process Control Group, Applied Global Services, Display and Adjacent Markets and other reporting units recorded under Corporate and Other. The Semiconductor Products Group and Imaging and Process Control Group combine to form the Semiconductor Systems reporting segment.
Leases	A contract contains a lease when we have the right to control the use of an identified asset for a period of time in exchange for consideration. A majority of our lease arrangements are operating leases. We also have certain leases that qualify as finance leases. We lease certain facilities, vehicles and equipment under non-cancelable operating leases, many of which include options to renew. Options that are reasonably certain to be exercised are included in the calculation of the right-of-use asset and lease liability. Our finance leases are those that contain a purchase option which we are reasonably certain to exercise at the end of the lease term. Our leases do not contain residual value guarantees or significant restrictions that impact the accounting for leases. As implicit rates are not available for the leases, we use the incremental borrowing rate as of the lease commencement date in order to measure the right-of-use asset and liability. Operating lease expense is generally recognized on a straight-line basis over the lease term. Finance lease expense is generally recognized on a straight-line basis over the life of the underlying leased asset. We elected the practical expedient to account for lease and non-lease components as a single lease component for all leases. For leases with a term of one year or less, we elected not to record a right-of-use asset or lease liability and to account for the associated lease payments as they become due.
Treasury Stock	We record treasury stock purchases under the cost method using the first-in, first-out (FIFO) method. Upon reissuance of treasury stock, amounts in excess of the acquisition cost are credited to additional paid in capital. If we reissue treasury stock at an amount below our acquisition cost and additional paid in capital associated with prior treasury stock transactions is insufficient to cover the difference between the acquisition cost and the reissue price, this difference is recorded against retained earnings.
Share-Based Compensation	The cost associated with share-based awards is typically recognized over the awards’ service period for the entire award on a straight-line basis, adjusting for estimated forfeitures. However, in the case of share-based awards granted to certain members of senior management that allow for partial accelerated vesting in the event of a qualifying retirement based on age and years of service, the compensation expense is recognized once the individual meets the conditions for a qualifying retirement. We calculate estimated forfeiture rate on an annual basis, based on historical forfeiture activities. The cost associated with performance-based equity awards, which include performance and/or market goals, is recognized for each tranche over the service period. The cost of the portion of performance-based equity awards subject to performance goals is recognized based on an assessment of the likelihood that the applicable performance goals will be achieved, and the cost of the portion of performance-based equity awards subject to market goals is recognized based on the assumption of 100% achievement of the goal.
Performance Based Awards	During the first half of fiscal 2024, certain members of senior management were granted awards that are subject to the achievement of targeted levels of adjusted operating margin and targeted levels of total shareholder return (TSR) relative to the TSR of the companies in the Standard & Poor's 500 Index. Each of these two metrics will be weighted 50% and will be measured over a three-year period. The number of shares that may vest in full after three years ranges from 0% to 200% of the target amount. The awards become eligible to vest only if the goals are achieved and will vest only if the grantee remains employed by us through each applicable vesting date, subject to a qualifying retirement based on age and years of service. The awards provide for a partial vesting based on actual performance at the conclusion of the three-year performance period in the event of a qualifying retirement. The fair value of the portion of the awards subject to targeted levels of relative TSR is estimated on the date of grant using a Monte Carlo simulation model. Compensation expense is recognized based upon the assumption of 100% achievement of the TSR goal and will not be reversed even if the threshold level of TSR is never achieved, and is reflected over the service period and reduced for estimated forfeitures. The fair value of the portion of the awards subject to targeted levels of adjusted operating margin is estimated on the date of grant. If the performance goals are not met as of the end of the performance period, no compensation expense is recognized and any previously recognized compensation expense is reversed. The expected cost is based on the portion of the awards that is probable to vest and is reflected over the service period and reduced for estimated forfeitures.
Warranty	Our products are generally sold with a warranty for a 12-month period following installation. The provision for the estimated cost of warranty is recorded when revenue is recognized. Parts and labor are covered under the terms of the warranty agreement. The warranty provision is based on historical experience by product, configuration and geographic region. Quarterly warranty consumption is generally associated with sales that occurred during the preceding four quarters, and quarterly warranty provisions are generally related to the current quarter’s sales.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Jul. 28, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share	Three Months Ended Nine Months Ended July 28, July 30, July 28, July 30, (In millions, except per share amounts) Numerator: Net income $ 1,705 $ 1,560 $ 5,446 $ 4,852 Denominator: Weighted average common shares outstanding 826 838 829 842 Effect of weighted dilutive restricted stock units and employee stock purchase plan shares 7 5 6 4 Denominator for diluted earnings per share 833 843 835 846 Basic earnings per share $ 2.06 $ 1.86 $ 6.57 $ 5.76 Diluted earnings per share $ 2.05 $ 1.85 $ 6.52 $ 5.73 Potentially weighted dilutive securities — — — 2

Cash, Cash Equivalents and In_2

Cash, Cash Equivalents and Investments (Tables)	9 Months Ended
	Jul. 28, 2024
Cash and Cash Equivalents [Abstract]
Schedule of Cash, Cash Equivalents and Investments	The following tables summarize our cash, cash equivalents and investments by security type: July 28, 2024 Cost Gross Gross Estimated (In millions) Cash $ 1,318 $ — $ — $ 1,318 Cash equivalents: Money market funds * 2,828 — — 2,828 Bank certificates of deposit and time deposits 20 — — 20 U.S. Treasury and agency securities 2,291 — — 2,291 Municipal securities 73 — — 73 Commercial paper, corporate bonds and medium-term notes 1,758 — — 1,758 Total cash equivalents 6,970 — — 6,970 Total cash and cash equivalents $ 8,288 $ — $ — $ 8,288 Short-term and long-term investments: Bank certificates of deposit and time deposits $ 19 $ — $ — $ 19 U.S. Treasury and agency securities 641 1 2 640 Non-U.S. government securities ** 5 — — 5 Municipal securities 445 2 4 443 Commercial paper, corporate bonds and medium-term notes 816 2 3 815 Asset-backed and mortgage-backed securities 632 1 6 627 Total fixed income securities 2,558 6 15 2,549 Publicly traded equity securities 543 422 3 962 Equity investments in privately held companies 246 58 19 285 Total equity investments 789 480 22 1,247 Total short-term and long-term investments $ 3,347 $ 486 $ 37 $ 3,796 Total cash, cash equivalents and investments $ 11,635 $ 486 $ 37 $ 12,084 _________________________ *Excludes $90 million of restricted cash equivalents invested in money market funds related to deferred compensation plans. **Includes Canadian provincial government debt. October 29, 2023 Cost Gross Gross Estimated (In millions) Cash $ 1,417 $ — $ — $ 1,417 Cash equivalents: Money market funds * 3,260 — — 3,260 Municipal securities 26 — — 26 Commercial paper, corporate bonds and medium-term notes 1,429 — — 1,429 Total cash equivalents 4,715 — — 4,715 Total cash and cash equivalents $ 6,132 $ — $ — $ 6,132 Short-term and long-term investments: Bank certificates of deposit and time deposits $ 18 $ — $ — $ 18 U.S. Treasury and agency securities 381 — 7 374 Non-U.S. government securities ** 7 — 1 6 Municipal securities 438 — 11 427 Commercial paper, corporate bonds and medium-term notes 760 — 12 748 Asset-backed and mortgage-backed securities 502 — 15 487 Total fixed income securities 2,106 — 46 2,060 Publicly traded equity securities 543 171 16 698 Equity investments in privately held companies 192 78 10 260 Total equity investments 735 249 26 958 Total short-term and long-term investments $ 2,841 $ 249 $ 72 $ 3,018 Total cash, cash equivalents and investments $ 8,973 $ 249 $ 72 $ 9,150 _________________________ *Excludes $101 million of restricted cash equivalents invested in money market funds related to deferred compensation plans. **Includes Canadian provincial government debt.
Schedule of Contractual Maturities of Investments	The following table summarizes the contractual maturities of our investments as of July 28, 2024: Cost Estimated (In millions) Due in one year or less $ 798 $ 796 Due after one through five years 1,124 1,122 Due after five years 4 4 No single maturity date* 1,421 1,874 Total $ 3,347 $ 3,796 _________________________ *Securities with no single maturity date include publicly traded and privately held equity securities and asset-backed and mortgage-backed securities.
Schedule of Components of Gain (Loss) on Equity Investment	The components of gain (loss) on equity investments for the three and nine months ended July 28, 2024 and July 30, 2023 were as follows: Three Months Ended Nine Months Ended July 28, July 30, July 28, July 30, (In millions) Publicly traded equity securities Unrealized gain $ 6 $ 12 $ 318 $ 31 Unrealized loss (30) (1) (33) (28) Realized gain on sales and dividends 3 4 5 5 Realized loss on sales or impairment — — (1) (2) Equity investments in privately held companies Unrealized gain 1 1 2 13 Unrealized loss (2) (18) (12) (29) Realized gain on sales and dividends — 2 3 7 Realized loss on sales or impairment (19) (2) (19) (119) Total gain (loss) on equity investments, net $ (41) $ (2) $ 263 $ (122)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Jul. 28, 2024
Fair Value Disclosures [Abstract]
Schedule of Financial Assets Measured at Fair Value on a Recurring Basis	Financial assets (excluding cash balances) measured at fair value on a recurring basis are summarized below: July 28, 2024 October 29, 2023 Level 1 Level 2 Total Level 1 Level 2 Total (In millions) Assets: Available-for-sale debt security investments Money market funds* $ 2,918 $ — $ 2,918 $ 3,361 $ — $ 3,361 Bank certificates of deposit and time deposits — 39 39 — 18 18 U.S. Treasury and agency securities 2,909 22 2,931 331 43 374 Non-U.S. government securities — 5 5 — 6 6 Municipal securities — 516 516 — 453 453 Commercial paper, corporate bonds and medium-term notes — 2,573 2,573 — 2,177 2,177 Asset-backed and mortgage-backed securities — 627 627 — 487 487 Total available-for-sale debt security investments $ 5,827 $ 3,782 $ 9,609 $ 3,692 $ 3,184 $ 6,876 Equity investments with readily determinable values Publicly traded equity securities $ 962 $ — $ 962 $ 698 $ — $ 698 Total equity investments with readily determinable values $ 962 $ — $ 962 $ 698 $ — $ 698 Total $ 6,789 $ 3,782 $ 10,571 $ 4,390 $ 3,184 $ 7,574 _________________________ deferred income taxes and other assets

Derivative Instruments and He_2

Derivative Instruments and Hedging Activities (Tables)	9 Months Ended
	Jul. 28, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments	The gain (loss) on derivatives in cash flow hedging relationships recognized in AOCI for derivatives designated as hedging instruments for the indicated periods were as follows: Three Months Ended Nine Months Ended July 28, July 30, July 28, July 30, (In millions) Derivatives in Cash Flow Hedging Relationships: Foreign exchange contracts $ 16 $ 15 $ 44 $ (32) Interest rate contracts (8) — 12 — Total $ 8 $ 15 $ 56 $ (32)
Schedule of Effect of Derivative Instruments on the Consolidated Statement of Operations	The effects of derivative instruments and hedging activities on the Consolidated Condensed Statements of Operations were as follows: Three Months Ended July 28, 2024 July 30, 2023 Derivatives in Cash Flow Hedging Relationships Derivatives in Cash Flow Hedging Relationships Total Amount Presented in the Consolidated Condensed Statement of Operations in which the Effects of Cash Flow Hedges are Recorded Amount of Gain or (Loss) Amount of Gain (Loss) Excluded from Effectiveness Testing Total Amount Presented in the Consolidated Condensed Statement of Operations in which the Effects of Cash Flow Hedges are Recorded Amount of Gain or (Loss) Amount of Gain (Loss) Excluded from Effectiveness Testing (In millions) Foreign Exchange Contracts: Net revenue $ 6,778 $ 7 $ — $ 6,425 $ 8 $ — Cost of products sold $ 3,573 (3) — $ 3,449 — — Research, development and engineering $ 836 (2) — $ 767 (5) — Marketing and selling $ 205 — — $ 193 (1) — General and administrative $ 222 (1) — $ 214 (1) — Interest Rate Contracts: Interest expense $ 63 (3) — $ 60 (4) — $ (2) $ — $ (3) $ — Nine Months Ended July 28, 2024 July 30, 2023 Derivatives in Cash Flow Hedging Relationships Derivatives in Cash Flow Hedging Relationships Total Amount Presented in the Consolidated Condensed Statement of Operations in which the Effects of Cash Flow Hedges are Recorded Amount of Gain or (Loss) Amount of Gain (Loss) Excluded from Effectiveness Testing Total Amount Presented in the Consolidated Condensed Statement of Operations in which the Effects of Cash Flow Hedges are Recorded Amount of Gain or (Loss) Amount of Gain (Loss) Excluded from Effectiveness Testing (In millions) Foreign Exchange Contracts: Net sales $ 20,131 $ 21 $ (1) $ 19,794 $ 47 $ — Cost of products sold $ 10,569 (4) — $ 10,579 2 — Research, development and engineering $ 2,375 (6) — $ 2,313 (8) — Marketing and selling $ 621 (1) — $ 584 (1) — General and administrative $ 745 (1) — $ 635 (2) — Interest Rate Contracts: Interest expense $ 181 (9) — $ 180 (10) — $ — $ (1) $ 28 $ —
Schedule of Derivatives Not Designated as Hedging Instruments in Statement of Operations	Amount of Gain or (Loss) Three Months Ended Nine Months Ended Location of Gain or July 28, July 30, July 28, July 30, (In millions) Derivatives Not Designated as Hedging Instruments Foreign exchange contracts Interest and other income, net $ 2 $ 11 $ 20 $ (25) Total return swaps - deferred compensation Cost of products sold 1 2 5 3 Total return swaps - deferred compensation Operating expenses 16 15 55 29 Total return swaps - deferred compensation Interest and other income, net (4) (4) (11) (8) Total $ 15 $ 24 $ 69 $ (1)

Contract Balances and Perform_2

Contract Balances and Performance Obligations (Tables)	9 Months Ended
	Jul. 28, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Contract Balances	Contract balances at the end of each reporting period were as follows: July 28, 2024 October 29, 2023 (In millions) Contract assets $ 324 $ 274 Contract liabilities $ 2,742 $ 2,975

Balance Sheet Detail (Tables)

Balance Sheet Detail (Tables)	9 Months Ended
	Jul. 28, 2024
Balance Sheet Detail [Abstract]
Schedule of Inventories	July 28, October 29, (In millions) Inventories Customer service spares $ 1,727 $ 1,589 Raw materials 1,688 1,653 Work-in-process 945 997 Finished goods Deferred cost of sales 267 413 Evaluation inventory 487 423 Manufactured on-hand inventory 454 650 Total finished goods 1,208 1,486 Total inventories $ 5,568 $ 5,725
Schedule of Other Current Assets	July 28, October 29, (In millions) Other Current Assets Prepaid income taxes and income taxes receivable $ 51 $ 412 Prepaid expenses and other 979 976 $ 1,030 $ 1,388
Schedule of Property, Plant and Equipment, Net	Useful Life July 28, October 29, (In years) (In millions) Property, Plant and Equipment, Net Land and improvements $ 436 $ 393 Buildings and improvements 3-30 2,314 2,194 Demonstration and manufacturing equipment 5-8 2,573 2,353 Furniture, fixtures and other equipment 3-5 806 762 Construction in progress 828 672 Gross property, plant and equipment 6,957 6,374 Accumulated depreciation (3,857) (3,651) $ 3,100 $ 2,723
Schedule of Deferred Income Taxes and Other Assets	July 28, October 29, (In millions) Deferred Income Taxes and Other Assets Non-current deferred income taxes $ 2,107 $ 1,729 Operating lease right-of-use assets 355 370 Finance lease right-of-use assets 91 108 Income tax receivables and other assets 348 345 $ 2,901 $ 2,552
Schedule of Accounts Payable and Accrued Expenses	July 28, October 29, (In millions) Accounts Payable and Accrued Expenses Accounts payable $ 1,470 $ 1,478 Compensation and employee benefits 995 1,024 Warranty 347 332 Dividends payable 330 267 Income taxes payable 365 282 Other accrued taxes 74 65 Interest payable 59 38 Operating lease liabilities, current 86 84 Finance lease liabilities, current 89 102 Other 572 625 $ 4,387 $ 4,297
Schedule of Other Liabilities	July 28, October 29, (In millions) Other Liabilities Defined and postretirement benefit plans $ 121 $ 126 Operating lease liabilities, non-current 239 252 Other 390 336 $ 750 $ 714

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Jul. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Details of goodwill as of July 28, 2024 and October 29, 2023 were as follows: July 28, October 29, (In millions) Goodwill by reportable segment Semiconductor Systems $ 2,460 $ 2,460 Applied Global Services 1,032 1,032 Display and Adjacent Markets 199 199 Corporate and Other 41 41 $ 3,732 $ 3,732
Schedule of Finite-Lived Intangible Assets	Details of intangible assets other than goodwill were as follows: July 28, 2024 October 29, 2023 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount (In millions) Intangible assets with finite lives: Semiconductor Systems $ 2,001 $ (1,744) $ 257 $ 2,001 $ (1,714) $ 287 Applied Global Services 79 (79) — 79 (78) 1 Display and Adjacent Markets 194 (194) — 194 (194) — Corporate and Other 37 (32) 5 36 (30) 6 Total intangible assets with finite lives $ 2,311 $ (2,049) $ 262 $ 2,310 $ (2,016) $ 294
Schedule of Future Estimated Amortization Expense	As of July 28, 2024, future estimated amortization expense of intangible assets with finite lives is expected to be as follows: Amortization Expense (In millions) 2024 (remaining 3 months) $ 10 2025 41 2026 40 2027 26 2028 23 Thereafter 122 Total $ 262

Borrowing Facilities and Debt (

Borrowing Facilities and Debt (Tables)	9 Months Ended
	Jul. 28, 2024
Debt Disclosure [Abstract]
Schedule of Debt Outstanding	Debt outstanding as of July 28, 2024 and October 29, 2023 was as follows: Principal Amount July 28, October 29, Effective Interest (In millions) Long-term debt: 3.900% Senior Notes Due 2025 $ 700 $ 700 3.944% April 1, October 1 3.300% Senior Notes Due 2027 1,200 1,200 3.342% April 1, October 1 4.800% Senior Notes Due 2029 700 — 4.844% June 15, December 15 1.750% Senior Notes Due 2030 750 750 1.792% June 1, December 1 5.100% Senior Notes Due 2035 500 500 5.127% April 1, October 1 5.850% Senior Notes Due 2041 600 600 5.879% June 15, December 15 4.350% Senior Notes Due 2047 1,000 1,000 4.361% April 1, October 1 2.750% Senior Notes Due 2050 750 750 2.773% June 1, December 1 6,200 5,500 Total unamortized discount (11) (11) Total unamortized debt issuance costs (31) (28) Total long-term debt $ 6,158 $ 5,461

Leases (Tables)

Leases (Tables)	9 Months Ended
	Jul. 28, 2024
Leases [Abstract]
Schedule of Lease Expense	The components of lease expense and supplemental information were as follows: Three Months Ended Nine Months Ended July 28, July 30, July 28, July 30, (In millions, except percentages) Operating lease cost $ 27 $ 25 $ 81 $ 78 Finance lease cost: Amortization of right-of-use assets $ 1 $ — $ 2 $ 1 Interest on lease liabilities $ 1 $ 1 $ 3 $ 2 Weighted-average remaining lease term (in years) - operating leases 5.5 5.8 Weighted-average remaining lease term (in years) - finance leases 0.2 1.1 Weighted-average discount rate - operating leases 3.2% 2.9% Weighted-average discount rate - finance leases 4.6% 4.6% Supplemental cash flow information related to leases are as follows: Nine Months Ended July 28, July 30, (In millions) Operating cash flows paid for operating leases $ 80 $ 89 Operating cash flows paid for finance leases $ 3 $ 2 Financing cash flows paid for finance leases $ 12 $ 8 Right-of-use assets obtained in exchange for operating lease liabilities $ 73 $ 83 Right-of-use assets obtained in exchange for finance lease liabilities $ — $ 109
Schedule of Operating Lease, Maturities of Lease Liabilities	As of July 28, 2024, the maturities of lease liabilities are as follows: Operating Leases Finance Leases Fiscal (In millions) 2024 (remaining 3 months) $ 21 $ 90 2025 96 — 2026 60 — 2027 47 — 2028 39 — Thereafter 93 — Total lease payments $ 356 $ 90 Less imputed interest (31) (1) Total $ 325 $ 89
Schedule of Finance Lease Maturities	As of July 28, 2024, the maturities of lease liabilities are as follows: Operating Leases Finance Leases Fiscal (In millions) 2024 (remaining 3 months) $ 21 $ 90 2025 96 — 2026 60 — 2027 47 — 2028 39 — Thereafter 93 — Total lease payments $ 356 $ 90 Less imputed interest (31) (1) Total $ 325 $ 89

Stockholders' Equity, Compreh_2

Stockholders' Equity, Comprehensive Income and Share-Based Compensation (Tables)	9 Months Ended
	Jul. 28, 2024
Equity [Abstract]
Schedule of Components of Accumulated Other Comprehensive Income (Loss), After-Tax Basis	Changes in the components of accumulated other comprehensive income (loss) (AOCI), net of tax, were as follows: Unrealized Gain (Loss) on Investments, Net Unrealized Gain (Loss) on Derivative Instruments Qualifying as Cash Flow Hedges Defined and Postretirement Benefit Plans Cumulative Translation Adjustments Total (in millions) Balance as of October 29, 2023 $ (50) $ (118) $ (62) $ 13 $ (217) Other comprehensive income (loss) before reclassifications 27 44 — — 71 Amounts reclassified out of AOCI 9 — (9) — — Other comprehensive income (loss), net of tax 36 44 (9) — 71 Balance as of July 28, 2024 $ (14) $ (74) $ (71) $ 13 $ (146) Unrealized Gain (Loss) on Investments, Net Unrealized Gain (Loss) on Derivative Instruments Qualifying as Cash Flow Hedges Defined and Postretirement Benefit Plans Cumulative Translation Adjustments Total (in millions) Balance as of October 30, 2022 $ (75) $ (52) $ (88) $ 13 $ (202) Other comprehensive income (loss) before reclassifications 16 (25) — — (9) Amounts reclassified out of AOCI 9 (21) — — (12) Other comprehensive income (loss), net of tax 25 (46) — — (21) Balance as of July 30, 2023 $ (50) $ (98) $ (88) $ 13 $ (223)
Schedule of Stock Repurchases	The following table summarizes our stock repurchases, including and excluding excise tax, for the three and nine months ended July 28, 2024 and July 30, 2023: Three Months Ended Nine Months Ended July 28, July 30, July 28, July 30, (in millions, except per share amount) Shares of common stock repurchased 4 4 13 13 Cost of stock repurchased (including excise tax) * $ 868 $ 443 $ 2,398 $ 1,497 Average price paid per share (including excise tax) * $ 222.82 $ 131.09 $ 189.90 $ 117.35 Cost of stock repurchased (excluding excise tax) $ 861 $ 439 $ 2,381 $ 1,489 Average price paid per share (excluding excise tax) $ 221.27 $ 129.86 $ 188.60 $ 116.70 (*) Stock repurchase amounts include the 1% surcharge on stock repurchases under the Inflation Reduction Act’s excise tax. This excise tax is recorded in equity and reduces the amount available under the repurchase program, as applicable.
Schedule of Effect of Share-Based Compensation on the Results of Operations	The effect of share-based compensation on the results of operations was as follows: Three Months Ended Nine Months Ended July 28, July 30, July 28, July 30, (In millions) Cost of products sold $ 33 $ 42 $ 98 $ 138 Research, development and engineering 53 42 163 137 Marketing and selling 17 13 53 42 General and administrative 29 17 122 58 Total share-based compensation $ 132 $ 114 $ 436 $ 375
Schedule of Restricted Stock Units And Restricted Stock Activity	A summary of the changes in restricted stock units, restricted stock, performance share units and performance units outstanding under our equity compensation plans during the nine months ended July 28, 2024 is presented below: Shares Weighted Average (In millions, except per share amounts) Outstanding as of October 29, 2023 12 $ 106.24 Granted 4 $ 148.07 Vested (4) $ 97.11 Canceled (1) $ 119.91 Outstanding as of July 28, 2024 11 $ 127.04
Schedule of Employee Stock Purchase Plan	Underlying assumptions used in the model are outlined in the following table: Nine Months Ended July 28, July 30, Dividend yield 0.76% 1.09% Expected volatility 35.6% 43.3% Risk-free interest rate 5.27% 5.14% Expected life (in years) 0.5 0.5 Weighted average estimated fair value $53.98 $32.47

Warranty, Guarantees, Commitm_2

Warranty, Guarantees, Commitments and Contingencies (Tables)	9 Months Ended
	Jul. 28, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Changes in the Warranty Reserves	Changes in the warranty reserves are presented below: Three Months Ended Nine Months Ended July 28 July 30 July 28 July 30 (In millions) Beginning balance $ 346 $ 310 $ 332 $ 286 Provisions for warranty 62 62 181 186 Changes in reserves related to preexisting warranty (8) (2) (14) — Consumption of reserves (53) (57) (152) (159) Ending balance $ 347 $ 313 $ 347 $ 313

Industry Segment Operations (Ta

Industry Segment Operations (Tables)	9 Months Ended
	Jul. 28, 2024
Segment Reporting [Abstract]
Schedule of Net Sales and Operating Income (Loss)	Net revenue and operating income (loss) for each reportable segment were as follows: Three Months Ended Nine Months Ended Net Revenue Operating Net Revenue Operating (In millions) July 28, 2024: Semiconductor Systems $ 4,924 $ 1,712 $ 14,734 $ 5,157 Applied Global Services 1,580 467 4,586 1,320 Display and Adjacent Markets 251 16 674 46 Corporate and Other 23 (253) 137 (702) Total $ 6,778 $ 1,942 $ 20,131 $ 5,821 July 30, 2023: Semiconductor Systems $ 4,676 $ 1,568 $ 14,815 $ 5,138 Applied Global Services 1,464 399 4,261 1,128 Display and Adjacent Markets 235 32 570 51 Corporate and Other 50 (197) 148 (634) Total $ 6,425 $ 1,802 $ 19,794 $ 5,683
Schedule of Revenue From External Customers by Geographic Areas	Net revenue by geographic region, determined by the location of customers’ facilities to which products were shipped to, were as follows: Three Months Ended Nine Months Ended July 28, July 30, Change July 28, July 30, Change (In millions, except percentages) China $ 2,153 32 % $ 1,734 27 % 24 % $ 7,981 40 % $ 4,284 22 % 86 % Korea 1,102 16 % 988 15 % 12 % 3,321 16 % 3,864 19 % (14) % Taiwan 1,148 17 % 1,345 21 % (15) % 2,726 14 % 4,748 24 % (43) % Japan 555 8 % 478 8 % 16 % 1,573 8 % 1,394 7 % 13 % Southeast Asia 428 6 % 180 3 % 138 % 827 4 % 590 3 % 40 % Asia Pacific 5,386 79 % 4,725 74 % 14 % 16,428 82 % 14,880 75 % 10 % United States 1,053 16 % 1,039 16 % 1 % 2,665 13 % 3,203 16 % (17) % Europe 339 5 % 661 10 % (49) % 1,038 5 % 1,711 9 % (39) % Total $ 6,778 100 % $ 6,425 100 % 5 % $ 20,131 100 % $ 19,794 100 % 2 %
Schedule of Disaggregation of Revenue	Net revenue for Semiconductor Systems by end use application for the periods indicated were as follows: Three Months Ended Nine Months Ended July 28, July 30, July 28, July 30, Foundry, logic and other 72 % 79 % 66 % 80 % Dynamic random-access memory (DRAM) 24 % 17 % 30 % 14 % Flash memory 4 % 4 % 4 % 6 % 100 % 100 % 100 % 100 %
Schedule of Reconciliations of Total Segment Operating Income to Consolidated Operating Income (Loss)	The reconciling items included in Corporate and Other were as follows: Three Months Ended Nine Months Ended July 28, July 30, July 28, July 30, (In millions) Unallocated net revenue $ 23 $ 50 $ 137 $ 148 Unallocated cost of products sold and expenses (276) (247) (839) (782) Total $ (253) $ (197) $ (702) $ (634)
Schedule of Companies Accounted for at Least 10 Percent of Net Sales	The following customer accounted for at least 10 percent of our net revenue for the nine months ended July 28, 2024, and sales to this customer included products and services from multiple reportable segments. Percentage of Net Revenue Samsung Electronics Co., Ltd. 12 %

Basis of Presentation (Details)

Basis of Presentation (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023
Property, Plant and Equipment [Line Items]
Basic earnings per share (in dollars per share)	$ 2.06	$ 1.86	$ 6.57	$ 5.76
Diluted earnings per share (in dollars per share)	$ 2.05	$ 1.85	$ 6.52	$ 5.73
Change in accounting estimate, useful life
Property, Plant and Equipment [Line Items]
Reduction in depreciation expense	$ 30		$ 97
Basic earnings per share (in dollars per share)	$ 0.03		$ 0.09
Diluted earnings per share (in dollars per share)	$ 0.03		$ 0.09
Buildings and improvements
Property, Plant and Equipment [Line Items]
Increase in useful life	5 years		5 years
Minimum | Demonstration and manufacturing equipment
Property, Plant and Equipment [Line Items]
Useful life	5 years		5 years
Minimum | Buildings and improvements
Property, Plant and Equipment [Line Items]
Useful life	3 years		3 years
Maximum | Demonstration and manufacturing equipment
Property, Plant and Equipment [Line Items]
Useful life	8 years		8 years
Maximum | Buildings and improvements
Property, Plant and Equipment [Line Items]
Useful life	30 years		30 years

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023
Numerator:
Net income	$ 1,705	$ 1,560	$ 5,446	$ 4,852
Denominator:
Weighted average common shares outstanding (in shares)	826	838	829	842
Effect of weighted dilutive restricted stock units and employee stock purchase plan shares (in shares)	7	5	6	4
Denominator for diluted earnings per share (in shares)	833	843	835	846
Basic earnings per share (in dollars per share)	$ 2.06	$ 1.86	$ 6.57	$ 5.76
Diluted earnings per share (in dollars per share)	$ 2.05	$ 1.85	$ 6.52	$ 5.73
Potentially weighted dilutive securities (in shares)	0	0	0	2

Cash, Cash Equivalents and In_3

Cash, Cash Equivalents and Investments - Summary of Cash, Cash Equivalents and Investments (Details) - USD ($) $ in Millions	Jul. 28, 2024	Oct. 29, 2023	Jul. 30, 2023
Summary of Cash, Cash Equivalents and Investments
Cash	$ 1,318	$ 1,417
Total cash equivalents	6,970	4,715
Total cash and cash equivalents	8,288	6,132	$ 6,025
Equity investments and equity securities without readily determinable, cost	789	735
Equity investments and equity securities without readily determinable, gross unrealized gains	480	249
Equity investments and equity securities without readily determinable, gross unrealized losses	22	26
Equity investments and equity securities without readily determinable, fair value	1,247	958
Total short-term and long-term investments cost	3,347	2,841
Gross unrealized gains on short-term and long-term investments	486	249
Gross unrealized losses on short-term and long-term investments	37	72
Total short-term and long-term investments	3,796	3,018
Cash, cash equivalents and investments, cost	11,635	8,973
Cash, cash equivalents and investments, gross unrealized gains	486	249
Cash, cash equivalents and investments, gross unrealized losses	37	72
Cash, cash equivalents and investments, estimated fair value	12,084	9,150
Restricted cash equivalents included in deferred income taxes and other assets	90		$ 108
Total fixed income securities
Summary of Cash, Cash Equivalents and Investments
Cost of fixed income securities	2,558	2,106
Gross unrealized gains on fixed income securities	6	0
Gross unrealized losses on fixed income securities	15	46
Estimated fair value of fixed income securities	2,549	2,060
Bank certificates of deposit and time deposits
Summary of Cash, Cash Equivalents and Investments
Cost of fixed income securities	19	18
Gross unrealized gains on fixed income securities	0	0
Gross unrealized losses on fixed income securities	0	0
Estimated fair value of fixed income securities	19	18
U.S. Treasury and agency securities
Summary of Cash, Cash Equivalents and Investments
Cost of fixed income securities	641	381
Gross unrealized gains on fixed income securities	1	0
Gross unrealized losses on fixed income securities	2	7
Estimated fair value of fixed income securities	640	374
Non-U.S. government securities
Summary of Cash, Cash Equivalents and Investments
Cost of fixed income securities	5	7
Gross unrealized gains on fixed income securities	0	0
Gross unrealized losses on fixed income securities	0	1
Estimated fair value of fixed income securities	5	6
Municipal securities
Summary of Cash, Cash Equivalents and Investments
Cost of fixed income securities	445	438
Gross unrealized gains on fixed income securities	2	0
Gross unrealized losses on fixed income securities	4	11
Estimated fair value of fixed income securities	443	427
Commercial paper, corporate bonds and medium-term notes
Summary of Cash, Cash Equivalents and Investments
Cost of fixed income securities	816	760
Gross unrealized gains on fixed income securities	2	0
Gross unrealized losses on fixed income securities	3	12
Estimated fair value of fixed income securities	815	748
Asset-backed and mortgage-backed securities
Summary of Cash, Cash Equivalents and Investments
Cost of fixed income securities	632	502
Gross unrealized gains on fixed income securities	1	0
Gross unrealized losses on fixed income securities	6	15
Estimated fair value of fixed income securities	627	487
Publicly traded equity securities
Summary of Cash, Cash Equivalents and Investments
Equity investments cost	543	543
Equity investments unrealized gains	422	171
Equity investments unrealized losses	3	16
Equity investments estimated fair value	962	698
Equity investments in privately held companies
Summary of Cash, Cash Equivalents and Investments
Equity securities without readily determinable, cost	246	192
Equity securities without readily determinable, fair value, gross unrealized gains	58	78
Equity securities without readily determinable, fair value, gross unrealized losses	19	10
Equity securities without readily determinable, fair value	285	260
Money market funds
Summary of Cash, Cash Equivalents and Investments
Total cash equivalents	2,828	3,260
Restricted cash equivalents included in deferred income taxes and other assets	90	101
Bank certificates of deposit and time deposits
Summary of Cash, Cash Equivalents and Investments
Total cash equivalents	20
U.S. Treasury and agency securities
Summary of Cash, Cash Equivalents and Investments
Total cash equivalents	2,291
Municipal securities
Summary of Cash, Cash Equivalents and Investments
Total cash equivalents	73	26
Commercial paper, corporate bonds and medium-term notes
Summary of Cash, Cash Equivalents and Investments
Total cash equivalents	$ 1,758	$ 1,429

Cash, Cash Equivalents and In_4

Cash, Cash Equivalents and Investments - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023
Cash and Cash Equivalents [Abstract]
Interest income, interest income	$ 124	$ 73	$ 345	$ 165

Cash, Cash Equivalents and In_5

Cash, Cash Equivalents and Investments - Summary of Contractual Maturity (Details) $ in Millions	Jul. 28, 2024 USD ($)
Contractual maturities of investments
Due in one year or less, Cost	$ 798
Due after one through five years, Cost	1,124
Due after five years, Cost	4
No single maturity date, Cost	1,421
Total short-term and long-term investments cost	3,347
Due in one year or less, Estimated Fair Value	796
Due after one through five years, Estimated Fair Value	1,122
Due after five years, Estimated Fair Value	4
No single maturity date, Estimated Fair Value	1,874
Estimated fair value of short-term and long-term investments	$ 3,796

Cash, Cash Equivalents and In_6

Cash, Cash Equivalents and Investments - Gain (Loss) on Equity Investments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023
Publicly traded equity securities
Unrealized gain	$ 6	$ 12	$ 318	$ 31
Unrealized loss	(30)	(1)	(33)	(28)
Realized gain on sales and dividends	3	4	5	5
Realized loss on sales or impairment	0	0	(1)	(2)
Equity investments in privately held companies
Unrealized gain	1	1	2	13
Unrealized loss	(2)	(18)	(12)	(29)
Realized gain on sales and dividends	0	2	3	7
Realized loss on sales or impairment	(19)	(2)	(19)	(119)
Total gain (loss) on equity investments, net	$ (41)	$ (2)	$ 263	$ (122)

Fair Value Measurements - Asset

Fair Value Measurements - Assets Measured at Fair Value (Details) - USD ($) $ in Millions	Jul. 28, 2024	Oct. 29, 2023	Jul. 30, 2023
Assets:
Restricted cash equivalents included in deferred income taxes and other assets	$ 90		$ 108
Restricted Cash Equivalents, Statement of Financial Position [Extensible Enumeration]	Deferred Income Taxes and Other Assets, Noncurrent	Deferred Income Taxes and Other Assets, Noncurrent
Money market funds
Assets:
Restricted cash equivalents included in deferred income taxes and other assets	$ 90	$ 101
Bank certificates of deposit and time deposits
Assets:
Available-for-sale debt security investments	19	18
U.S. Treasury and agency securities
Assets:
Available-for-sale debt security investments	640	374
Non-U.S. government securities
Assets:
Available-for-sale debt security investments	5	6
Municipal securities
Assets:
Available-for-sale debt security investments	443	427
Commercial paper, corporate bonds and medium-term notes
Assets:
Available-for-sale debt security investments	815	748
Asset-backed and mortgage-backed securities
Assets:
Available-for-sale debt security investments	627	487
Publicly traded equity securities
Assets:
Equity investments with readily determinable values	962	698
Recurring Fair Value Measurements
Assets:
Available-for-sale debt security investments	9,609	6,876
Equity investments with readily determinable values	962	698
Total	10,571	7,574
Recurring Fair Value Measurements | Money market funds
Assets:
Available-for-sale debt security investments	2,918	3,361
Recurring Fair Value Measurements | Bank certificates of deposit and time deposits
Assets:
Available-for-sale debt security investments	39	18
Recurring Fair Value Measurements | U.S. Treasury and agency securities
Assets:
Available-for-sale debt security investments	2,931	374
Recurring Fair Value Measurements | Non-U.S. government securities
Assets:
Available-for-sale debt security investments	5	6
Recurring Fair Value Measurements | Municipal securities
Assets:
Available-for-sale debt security investments	516	453
Recurring Fair Value Measurements | Commercial paper, corporate bonds and medium-term notes
Assets:
Available-for-sale debt security investments	2,573	2,177
Recurring Fair Value Measurements | Asset-backed and mortgage-backed securities
Assets:
Available-for-sale debt security investments	627	487
Recurring Fair Value Measurements | Publicly traded equity securities
Assets:
Equity investments with readily determinable values	962	698
Recurring Fair Value Measurements | Level 1
Assets:
Available-for-sale debt security investments	5,827	3,692
Equity investments with readily determinable values	962	698
Total	6,789	4,390
Recurring Fair Value Measurements | Level 1 | Money market funds
Assets:
Available-for-sale debt security investments	2,918	3,361
Recurring Fair Value Measurements | Level 1 | Bank certificates of deposit and time deposits
Assets:
Available-for-sale debt security investments	0	0
Recurring Fair Value Measurements | Level 1 | U.S. Treasury and agency securities
Assets:
Available-for-sale debt security investments	2,909	331
Recurring Fair Value Measurements | Level 1 | Non-U.S. government securities
Assets:
Available-for-sale debt security investments	0	0
Recurring Fair Value Measurements | Level 1 | Municipal securities
Assets:
Available-for-sale debt security investments	0	0
Recurring Fair Value Measurements | Level 1 | Commercial paper, corporate bonds and medium-term notes
Assets:
Available-for-sale debt security investments	0	0
Recurring Fair Value Measurements | Level 1 | Asset-backed and mortgage-backed securities
Assets:
Available-for-sale debt security investments	0	0
Recurring Fair Value Measurements | Level 1 | Publicly traded equity securities
Assets:
Equity investments with readily determinable values	962	698
Recurring Fair Value Measurements | Level 2
Assets:
Available-for-sale debt security investments	3,782	3,184
Equity investments with readily determinable values	0	0
Total	3,782	3,184
Recurring Fair Value Measurements | Level 2 | Money market funds
Assets:
Available-for-sale debt security investments	0	0
Recurring Fair Value Measurements | Level 2 | Bank certificates of deposit and time deposits
Assets:
Available-for-sale debt security investments	39	18
Recurring Fair Value Measurements | Level 2 | U.S. Treasury and agency securities
Assets:
Available-for-sale debt security investments	22	43
Recurring Fair Value Measurements | Level 2 | Non-U.S. government securities
Assets:
Available-for-sale debt security investments	5	6
Recurring Fair Value Measurements | Level 2 | Municipal securities
Assets:
Available-for-sale debt security investments	516	453
Recurring Fair Value Measurements | Level 2 | Commercial paper, corporate bonds and medium-term notes
Assets:
Available-for-sale debt security investments	2,573	2,177
Recurring Fair Value Measurements | Level 2 | Asset-backed and mortgage-backed securities
Assets:
Available-for-sale debt security investments	627	487
Recurring Fair Value Measurements | Level 2 | Publicly traded equity securities
Assets:
Equity investments with readily determinable values	$ 0	$ 0

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023	Oct. 29, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impairment losses on equity investments	$ 0	$ 0	$ 0	$ 119
Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-term debt, principal amount	6,200		6,200		$ 5,500
Senior Notes | Level 2 | Estimate of Fair Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-term debt fair value	$ 5,700		$ 5,700		$ 4,700

Derivative Instruments and He_3

Derivative Instruments and Hedging Activities - Narrative (Details) - USD ($) $ in Billions	9 Months Ended
	Jul. 28, 2024	Oct. 29, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Time period for hedging of foreign currency transaction	24 months
Time period over which majority of after tax gain loss related to derivatives to be reclassified into earnings	12 months
Foreign exchange contracts
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, notional amount	$ 1.6	$ 1.7

Derivative Instruments and He_4

Derivative Instruments and Hedging Activities - Gain (Loss) on Derivatives in AOCI (Details) - Cash Flow Hedging - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023
Derivative Instruments, Gain (Loss) [Line Items]
Effective portion - gain (loss) recognized in AOCI	$ 8	$ 15	$ 56	$ (32)
Foreign exchange contracts
Derivative Instruments, Gain (Loss) [Line Items]
Effective portion - gain (loss) recognized in AOCI	16	15	44	(32)
Interest rate contracts
Derivative Instruments, Gain (Loss) [Line Items]
Effective portion - gain (loss) recognized in AOCI	$ (8)	$ 0	$ 12	$ 0

Derivative Instruments and He_5

Derivative Instruments and Hedging Activities - Derivatives in Statements of Operations (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023
Derivative Instruments, Gain (Loss) [Line Items]
Net revenue	$ 6,778	$ 6,425	$ 20,131	$ 19,794
Cost of products sold	3,573	3,449	10,569	10,579
Research, development and engineering	836	767	2,375	2,313
Marketing and selling	205	193	621	584
General and administrative	222	214	745	635
Interest expense	63	60	181	180
Amount of Gain or (Loss) Reclassified from AOCI into Consolidated Condensed Statement of Operations	(2)	(3)	0	28
Amount of Gain (Loss) Excluded from Effectiveness Testing Recognized in Consolidated Condensed Statement of Operations	0	0	(1)	0
Foreign exchange contracts | Net revenue
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Reclassified from AOCI into Consolidated Condensed Statement of Operations	7	8	21	47
Amount of Gain (Loss) Excluded from Effectiveness Testing Recognized in Consolidated Condensed Statement of Operations	0	0	(1)	0
Foreign exchange contracts | Cost of products sold
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Reclassified from AOCI into Consolidated Condensed Statement of Operations	(3)	0	(4)	2
Amount of Gain (Loss) Excluded from Effectiveness Testing Recognized in Consolidated Condensed Statement of Operations	0	0	0	0
Foreign exchange contracts | Research, development and engineering
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Reclassified from AOCI into Consolidated Condensed Statement of Operations	(2)	(5)	(6)	(8)
Amount of Gain (Loss) Excluded from Effectiveness Testing Recognized in Consolidated Condensed Statement of Operations	0	0	0	0
Foreign exchange contracts | Marketing and selling
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Reclassified from AOCI into Consolidated Condensed Statement of Operations	0	(1)	(1)	(1)
Amount of Gain (Loss) Excluded from Effectiveness Testing Recognized in Consolidated Condensed Statement of Operations	0	0	0	0
Foreign exchange contracts | General and administrative
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Reclassified from AOCI into Consolidated Condensed Statement of Operations	(1)	(1)	(1)	(2)
Amount of Gain (Loss) Excluded from Effectiveness Testing Recognized in Consolidated Condensed Statement of Operations	0	0	0	0
Interest rate contracts | Interest expense
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Reclassified from AOCI into Consolidated Condensed Statement of Operations	(3)	(4)	(9)	(10)
Amount of Gain (Loss) Excluded from Effectiveness Testing Recognized in Consolidated Condensed Statement of Operations	$ 0	$ 0	$ 0	$ 0

Derivative Instruments and He_6

Derivative Instruments and Hedging Activities - Gain/Loss Recognized in Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivatives not designated as hedging instruments	$ 15	$ 24	$ 69	$ (1)
Foreign exchange contracts | Interest and other income, net
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivatives not designated as hedging instruments	2	11	20	(25)
Total return swaps - deferred compensation | Interest and other income, net
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivatives not designated as hedging instruments	(4)	(4)	(11)	(8)
Total return swaps - deferred compensation | Cost of products sold
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivatives not designated as hedging instruments	1	2	5	3
Total return swaps - deferred compensation | Operating expenses
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivatives not designated as hedging instruments	$ 16	$ 15	$ 55	$ 29

Accounts Receivable, Net (Detai

Accounts Receivable, Net (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023	Oct. 29, 2023
Receivables [Abstract]
Factored accounts receivable	$ 131,000,000	$ 90,000,000	$ 395,000,000	$ 619,000,000
Discounted letters of credit	0	0	0	0
Discounted promissory notes	0	$ 0	0	$ 0
Allowance for credit losses	$ 29,000,000		$ 29,000,000		$ 29,000,000

Contract Balances and Perform_3

Contract Balances and Performance Obligations - Schedule of Contract Assets and Liabilities (Details) - USD ($) $ in Millions	Jul. 28, 2024	Oct. 29, 2023
Revenue from Contract with Customer [Abstract]
Contract assets	$ 324	$ 274
Contract liabilities	$ 2,742	$ 2,975

Contract Balances and Perform_4

Contract Balances and Performance Obligations - Narrative (Details) - USD ($)	9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue recognized	$ 2,500,000,000
Accounts receivable, credit losses	0	$ 0
Contract assets, credit losses	0	$ 0
Long-term Contract with Customer
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation	$ 4,200,000,000
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-07-29 | Long-term Contract with Customer
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Percent of revenue expected to be recognized within twelve months	63%
Expected timing of satisfaction	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-07-29 | Long-term Contract with Customer
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Expected timing of satisfaction	24 months

Balance Sheet Detail - Inventor

Balance Sheet Detail - Inventories (Details) - USD ($) $ in Millions	Jul. 28, 2024	Oct. 29, 2023
Inventories
Customer service spares	$ 1,727	$ 1,589
Raw materials	1,688	1,653
Work-in-process	945	997
Finished goods
Deferred cost of sales	267	413
Evaluation inventory	487	423
Manufactured on-hand inventory	454	650
Total finished goods	1,208	1,486
Total inventories	$ 5,568	$ 5,725

Balance Sheet Detail - Other Cu

Balance Sheet Detail - Other Current Assets (Details) - USD ($) $ in Millions	Jul. 28, 2024	Oct. 29, 2023
Other Current Assets
Prepaid income taxes and income taxes receivable	$ 51	$ 412
Prepaid expenses and other	979	976
Total other current assets	$ 1,030	$ 1,388

Balance Sheet Detail - Property

Balance Sheet Detail - Property, Plant and Equipment (Details) - USD ($) $ in Millions	Jul. 28, 2024	Oct. 29, 2023
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	$ 6,957	$ 6,374
Accumulated depreciation	(3,857)	(3,651)
Net property, plant and equipment	3,100	2,723
Land and improvements
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	436	393
Buildings and improvements
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	$ 2,314	2,194
Buildings and improvements | Minimum
Property, Plant and Equipment [Line Items]
Useful Life	3 years
Buildings and improvements | Maximum
Property, Plant and Equipment [Line Items]
Useful Life	30 years
Demonstration and manufacturing equipment
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	$ 2,573	2,353
Demonstration and manufacturing equipment | Minimum
Property, Plant and Equipment [Line Items]
Useful Life	5 years
Demonstration and manufacturing equipment | Maximum
Property, Plant and Equipment [Line Items]
Useful Life	8 years
Furniture, fixtures and other equipment
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	$ 806	762
Furniture, fixtures and other equipment | Minimum
Property, Plant and Equipment [Line Items]
Useful Life	3 years
Furniture, fixtures and other equipment | Maximum
Property, Plant and Equipment [Line Items]
Useful Life	5 years
Construction in progress
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	$ 828	$ 672

Balance Sheet Detail - Deferred

Balance Sheet Detail - Deferred Income Taxes and Other Assets (Details) - USD ($) $ in Millions	Jul. 28, 2024	Oct. 29, 2023
Balance Sheet Detail [Abstract]
Non-current deferred income taxes	$ 2,107	$ 1,729
Operating lease right-of-use assets	355	370
Finance lease right-of-use assets	91	108
Income tax receivables and other assets	348	345
Deferred income taxes and other assets	$ 2,901	$ 2,552

Balance Sheet Detail - Accounts

Balance Sheet Detail - Accounts Payable and Accrued Expense (Details) - USD ($) $ in Millions	Jul. 28, 2024	Oct. 29, 2023
Accounts Payable and Accrued Expenses
Accounts payable	$ 1,470	$ 1,478
Compensation and employee benefits	995	1,024
Warranty	347	332
Dividends payable	330	267
Income taxes payable	365	282
Other accrued taxes	74	65
Interest payable	59	38
Operating lease liabilities, current	86	84
Finance lease liabilities, current	89	102
Other	572	625
Accounts payable and accrued expenses	$ 4,387	$ 4,297

Balance Sheet Detail - Other Li

Balance Sheet Detail - Other Liabilities (Details) - USD ($) $ in Millions	Jul. 28, 2024	Oct. 29, 2023
Other Liabilities
Defined and postretirement benefit plans	$ 121	$ 126
Operating lease liabilities, non-current	239	252
Other	390	336
Total other liabilities	$ 750	$ 714

Balance Sheet Detail - Narrativ

Balance Sheet Detail - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Jul. 28, 2024	Jul. 28, 2024
Government Assistance [Line Items]
Government assistance, asset, decrease		$ 279
Government Assistance, Asset, Decrease, Noncurrent, Statement of Financial Position [Extensible Enumeration]		Property, Plant and Equipment, Net
Government assistance, liability, decrease		$ 112
Accounts payable and accrued expenses
Government Assistance [Line Items]
Government assistance, liability, decrease		105
Income taxes payable
Government Assistance [Line Items]
Government assistance, liability, decrease		7
Contra-depreciation expense
Government Assistance [Line Items]
Government assistance, operating expense, decrease	$ 0	0
Research, development and engineering
Government Assistance [Line Items]
Government assistance, operating expense, decrease	$ 10	$ 32

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Schedule of Goodwill and Other Indefinite-lived Intangible Assets (Details) - USD ($) $ in Millions	Jul. 28, 2024	Oct. 29, 2023
Goodwill [Line Items]
Goodwill	$ 3,732	$ 3,732
Corporate and Other
Goodwill [Line Items]
Goodwill	41	41
Semiconductor Systems | Operating Segments
Goodwill [Line Items]
Goodwill	2,460	2,460
Applied Global Services | Operating Segments
Goodwill [Line Items]
Goodwill	1,032	1,032
Display and Adjacent Markets | Operating Segments
Goodwill [Line Items]
Goodwill	$ 199	$ 199

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Schedule of Finite-lived Intangible Assets (Details) - USD ($) $ in Millions	Jul. 28, 2024	Oct. 29, 2023
Intangible assets with finite lives:
Gross Carrying Amount	$ 2,311	$ 2,310
Accumulated Amortization	(2,049)	(2,016)
Total	262	294
Operating Segments | Semiconductor Systems
Intangible assets with finite lives:
Gross Carrying Amount	2,001	2,001
Accumulated Amortization	(1,744)	(1,714)
Total	257	287
Operating Segments | Applied Global Services
Intangible assets with finite lives:
Gross Carrying Amount	79	79
Accumulated Amortization	(79)	(78)
Total	0	1
Operating Segments | Display and Adjacent Markets
Intangible assets with finite lives:
Gross Carrying Amount	194	194
Accumulated Amortization	(194)	(194)
Total	0	0
Corporate and Other
Intangible assets with finite lives:
Gross Carrying Amount	37	36
Accumulated Amortization	(32)	(30)
Total	$ 5	$ 6

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense of intangible assets	$ 11	$ 11	$ 33	$ 34

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Estimated Amortization Expense (Details) - USD ($) $ in Millions	Jul. 28, 2024	Oct. 29, 2023
Amortization Expense
2024 (remaining 3 months)	$ 10
2025	41
2026	40
2027	26
2028	23
Thereafter	122
Total	$ 262	$ 294

Borrowing Facilities and Debt -

Borrowing Facilities and Debt - Narrative (Details) - USD ($)	1 Months Ended
	Feb. 29, 2020	Jul. 28, 2024	Jun. 30, 2024	Oct. 29, 2023
Debt Instrument [Line Items]
Short-term debt		$ 99,000,000		$ 100,000,000
Commercial Paper
Debt Instrument [Line Items]
Commercial paper		1,500,000,000
Short-term debt		$ 100,000,000		$ 100,000,000
Debt, weighted average interest rate		5.34%		5.39%
Debt securities, held-to-maturity, threshold period past due		98 days		90 days
Foreign Line of Credit
Debt Instrument [Line Items]
Available credit agreement		$ 52,000,000
Outstanding credit facilities		0		$ 0
Unsecured Debt | Revolving Credit
Debt Instrument [Line Items]
Debt instrument, term	5 years
Available credit agreement	$ 1,500,000,000
Accordion feature, increase limit	500,000,000
Accordion feature, higher borrowing capacity option	$ 2,000,000,000
Outstanding credit facilities		0		0
Senior Notes
Debt Instrument [Line Items]
Long-term debt, principal amount		6,200,000,000		5,500,000,000
Senior Notes | 4.800% Senior Notes Due 2029
Debt Instrument [Line Items]
Long-term debt, principal amount		$ 700,000,000		$ 0
Debt instrument, face amount			$ 700,000,000
Stated interest rate		4.80%	4.80%

Borrowing Facilities and Debt_2

Borrowing Facilities and Debt - Debt Outstanding (Details) - USD ($) $ in Millions	Jul. 28, 2024	Jun. 30, 2024	Oct. 29, 2023
Debt Instrument [Line Items]
Total long-term senior notes	$ 6,158		$ 5,461
Senior Notes
Debt Instrument [Line Items]
Long-term debt, principal amount	6,200		5,500
Total unamortized discount	(11)		(11)
Total unamortized debt issuance costs	$ (31)		(28)
Senior Notes | 3.900% Senior Notes Due 2025
Debt Instrument [Line Items]
Stated interest rate	3.90%
Long-term debt, principal amount	$ 700		700
Effective Interest Rate	3.944%
Senior Notes | 3.300% Senior Notes Due 2027
Debt Instrument [Line Items]
Stated interest rate	3.30%
Long-term debt, principal amount	$ 1,200		1,200
Effective Interest Rate	3.342%
Senior Notes | 4.800% Senior Notes Due 2029
Debt Instrument [Line Items]
Stated interest rate	4.80%	4.80%
Long-term debt, principal amount	$ 700		0
Effective Interest Rate	4.844%
Senior Notes | 1.750% Senior Notes Due 2030
Debt Instrument [Line Items]
Stated interest rate	1.75%
Long-term debt, principal amount	$ 750		750
Effective Interest Rate	1.792%
Senior Notes | 5.100% Senior Notes Due 2035
Debt Instrument [Line Items]
Stated interest rate	5.10%
Long-term debt, principal amount	$ 500		500
Effective Interest Rate	5.127%
Senior Notes | 5.850% Senior Notes Due 2041
Debt Instrument [Line Items]
Stated interest rate	5.85%
Long-term debt, principal amount	$ 600		600
Effective Interest Rate	5.879%
Senior Notes | 4.350% Senior Notes Due 2047
Debt Instrument [Line Items]
Stated interest rate	4.35%
Long-term debt, principal amount	$ 1,000		1,000
Effective Interest Rate	4.361%
Senior Notes | 2.750% Senior Notes Due 2050
Debt Instrument [Line Items]
Stated interest rate	2.75%
Long-term debt, principal amount	$ 750		$ 750
Effective Interest Rate	2.773%

Leases - Lease Expense and Supp

Leases - Lease Expense and Supplemental Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023
Leases [Abstract]
Operating lease cost	$ 27	$ 25	$ 81	$ 78
Amortization of right-of-use assets	1	0	2	1
Interest on lease liabilities	$ 1	$ 1	$ 3	$ 2
Weighted-average remaining lease term (in years) - operating leases	5 years 6 months	5 years 9 months 18 days	5 years 6 months	5 years 9 months 18 days
Weighted-average remaining lease term (in years) - finance leases	2 months 12 days	1 year 1 month 6 days	2 months 12 days	1 year 1 month 6 days
Weighted-average discount rate - operating leases	3.20%	2.90%	3.20%	2.90%
Weighted-average discount rate - finance leases	4.60%	4.60%	4.60%	4.60%
Operating cash flows paid for operating leases			$ 80	$ 89
Financing cash flows paid for finance leases			12	8
Right-of-use assets obtained in exchange for operating lease liabilities			73	83
Right-of-use assets obtained in exchange for finance lease liabilities			$ 0	$ 109

Leases - Lease Maturities (Deta

Leases - Lease Maturities (Details) $ in Millions	Jul. 28, 2024 USD ($)
Operating Leases
2024 (remaining 3 months)	$ 21
2025	96
2026	60
2027	47
2028	39
Thereafter	93
Total lease payments	356
Less imputed interest	(31)
Total	325
Finance Leases
2024 (remaining 3 months)	90
2025	0
2026	0
2027	0
2028	0
Thereafter	0
Total lease payments	90
Less imputed interest	(1)
Total	$ 89

Stockholders' Equity, Compreh_3

Stockholders' Equity, Comprehensive Income and Share-Based Compensation - Changes in Components of AOCI (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning balance	$ 18,199	$ 14,129	$ 16,349	$ 12,194
Other comprehensive income (loss) before reclassifications			71	(9)
Amounts reclassified out of AOCI			0	(12)
Other comprehensive income (loss), net of tax	26	12	71	(21)
Ending balance	18,840	15,093	18,840	15,093
AOCI Attributable to Parent
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning balance	(172)	(235)	(217)	(202)
Other comprehensive income (loss), net of tax	26	12	71	(21)
Ending balance	(146)	(223)	(146)	(223)
Unrealized Gain (Loss) on Investments, Net
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning balance			(50)	(75)
Other comprehensive income (loss) before reclassifications			27	16
Amounts reclassified out of AOCI			9	9
Other comprehensive income (loss), net of tax			36	25
Ending balance	(14)	(50)	(14)	(50)
Unrealized Gain (Loss) on Derivative Instruments Qualifying as Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning balance			(118)	(52)
Other comprehensive income (loss) before reclassifications			44	(25)
Amounts reclassified out of AOCI			0	(21)
Other comprehensive income (loss), net of tax			44	(46)
Ending balance	(74)	(98)	(74)	(98)
Defined and Postretirement Benefit Plans
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning balance			(62)	(88)
Other comprehensive income (loss) before reclassifications			0	0
Amounts reclassified out of AOCI			(9)	0
Other comprehensive income (loss), net of tax			(9)	0
Ending balance	(71)	(88)	(71)	(88)
Cumulative Translation Adjustments
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning balance			13	13
Other comprehensive income (loss) before reclassifications			0	0
Amounts reclassified out of AOCI			0	0
Other comprehensive income (loss), net of tax			0	0
Ending balance	$ 13	$ 13	$ 13	$ 13

Stockholders' Equity, Compreh_4

Stockholders' Equity, Comprehensive Income and Share-Based Compensation - Narrative (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	1 Months Ended			3 Months Ended		9 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023	Mar. 31, 2023	Mar. 31, 2022
Equity [Line Items]
Amount authorized by board of directors to repurchase shares								$ 10,000	$ 6,000
Remaining authorized repurchase amount				$ 10,300		$ 10,300
Dividends declared per share (in dollars per share)	$ 0.40	$ 0.40	$ 0.32	$ 0.40	$ 0.32	$ 1.12	$ 0.90
Payments of dividends						$ 863	$ 707
Employee Stock Incentive Plan
Equity [Line Items]
Number of shares available for grant (in shares)				21		21
Employee Stock Purchase Plan
Equity [Line Items]
Number of shares available for grant (in shares)				11		11
Employee stock purchase plan purchase period						6 months
Shares issued under employee stock purchase plans (in shares)						1	1
Employee Stock
Equity [Line Items]
Performance of total shareholder return						100%
Total unrecognized compensation expense				$ 977		$ 977
Weighted average period for unrecognized compensation expense to be recognized						2 years 8 months 12 days
Employee Stock | Employee Stock Purchase Plan
Equity [Line Items]
Purchase price of common stock						85%
Performance Shares
Equity [Line Items]
Additional performance-based awards to be earned upon certain levels of achievement (in shares)				0.7		0.7
Award measurement metric relative weight						50%
Award measurement period						3 years
Performance Shares | Minimum
Equity [Line Items]
Award vesting rights, percentage of target amount						0%
Performance Shares | Maximum
Equity [Line Items]
Award vesting rights, percentage of target amount						200%

Stockholders' Equity, Compreh_5

Stockholders' Equity, Comprehensive Income and Share-Based Compensation - Stock Repurchase Program (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023
Equity [Abstract]
Shares of common stock repurchases (in shares)	4	4	13	13
Cost of stock repurchased (including excise tax)	$ 868	$ 443	$ 2,398	$ 1,497
Average price paid per share (including excise tax) (in dollars per share)	$ 222.82	$ 131.09	$ 189.90	$ 117.35
Cost of stock repurchased (excluding excise tax)	$ 861	$ 439	$ 2,381	$ 1,489
Average price paid per share (excluding excise tax) (in dollars per share)	$ 221.27	$ 129.86	$ 188.60	$ 116.70

Stockholders' Equity, Compreh_6

Stockholders' Equity, Comprehensive Income and Share-Based Compensation - Share-Based Compensation (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total share-based compensation	$ 132	$ 114	$ 436	$ 375
Cost of products sold
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total share-based compensation	33	42	98	138
Research, development and engineering
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total share-based compensation	53	42	163	137
Marketing and selling
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total share-based compensation	17	13	53	42
General and administrative
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total share-based compensation	$ 29	$ 17	$ 122	$ 58

Stockholders' Equity, Compreh_7

Stockholders' Equity, Comprehensive Income and Share-Based Compensation - Restricted Stock Units, Restricted Stock, Performance Shares and Performance Units (Details) - Restricted Stock Units, Restricted Stock, Performance Shares and Performance Units shares in Millions	9 Months Ended
	Jul. 28, 2024 $ / shares shares
Shares
Beginning balance (in shares) | shares	12
Granted (in shares) | shares	4
Vested (in shares) | shares	(4)
Canceled (in shares) | shares	(1)
Ending balance (in shares) | shares	11
Weighted Average Grant Date Fair Value
Beginning balance (in dollars per share) | $ / shares	$ 106.24
Granted (in dollars per share) | $ / shares	148.07
Vested (in dollars per share) | $ / shares	97.11
Canceled (in dollars per share) | $ / shares	119.91
Ending balance (in dollars per share) | $ / shares	$ 127.04

Stockholders' Equity, Compreh_8

Stockholders' Equity, Comprehensive Income and Share-Based Compensation - Employee Stock Purchase Plan, Valuation Assumptions (Details) - Employee Stock Purchase Plan - $ / shares	9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield	0.76%	1.09%
Expected volatility	35.60%	43.30%
Risk-free interest rate	5.27%	5.14%
Expected life (in years)	6 months	6 months
Weighted average estimated fair value (in dollars per share)	$ 53.98	$ 32.47

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended		9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023
Income Tax Disclosure [Abstract]
Effective income tax rate provision	13%	13.60%	13%	12.50%

Warranty, Guarantees, Commitm_3

Warranty, Guarantees, Commitments and Contingencies - Rollforward (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023
Movement in Standard Product Warranty Accrual [Roll Forward]
Beginning balance	$ 346	$ 310	$ 332	$ 286
Provisions for warranty	62	62	181	186
Changes in reserves related to preexisting warranty	(8)	(2)	(14)	0
Consumption of reserves	(53)	(57)	(152)	(159)
Ending balance	$ 347	$ 313	$ 347	$ 313

Warranty, Guarantees, Commitm_4

Warranty, Guarantees, Commitments and Contingencies - Narrative (Details) $ in Millions	Jul. 28, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Standard product warranty period	12 months
Maximum potential amount of future payments for letters of credit or other guarantee instruments	$ 308
Parent guarantees to banks	$ 292

Industry Segment Operations - N

Industry Segment Operations - Narrative (Details)	9 Months Ended
	Jul. 28, 2024 Segment
Segment Reporting [Abstract]
Number of reportable segments	3

Industry Segment Operations -_2

Industry Segment Operations - Net Sales and Operating Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023
Segment Reporting Information [Line Items]
Net revenue	$ 6,778	$ 6,425	$ 20,131	$ 19,794
Operating Income (Loss)	1,942	1,802	5,821	5,683
Corporate and Other
Segment Reporting Information [Line Items]
Net revenue	23	50	137	148
Operating Income (Loss)	(253)	(197)	(702)	(634)
Semiconductor Systems | Operating Segments
Segment Reporting Information [Line Items]
Net revenue	4,924	4,676	14,734	14,815
Operating Income (Loss)	1,712	1,568	5,157	5,138
Applied Global Services | Operating Segments
Segment Reporting Information [Line Items]
Net revenue	1,580	1,464	4,586	4,261
Operating Income (Loss)	467	399	1,320	1,128
Display and Adjacent Markets | Operating Segments
Segment Reporting Information [Line Items]
Net revenue	251	235	674	570
Operating Income (Loss)	$ 16	$ 32	$ 46	$ 51

Industry Segment Operations -_3

Industry Segment Operations - Net Sales by Geographic Region (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023
Segment Reporting Information [Line Items]
Net revenue	$ 6,778	$ 6,425	$ 20,131	$ 19,794
Change	5%		2%
Asia Pacific
Segment Reporting Information [Line Items]
Net revenue	$ 5,386	4,725	$ 16,428	14,880
Change	14%		10%
China
Segment Reporting Information [Line Items]
Net revenue	$ 2,153	1,734	$ 7,981	4,284
Change	24%		86%
Korea
Segment Reporting Information [Line Items]
Net revenue	$ 1,102	988	$ 3,321	3,864
Change	12%		(14.00%)
Taiwan
Segment Reporting Information [Line Items]
Net revenue	$ 1,148	1,345	$ 2,726	4,748
Change	(15.00%)		(43.00%)
Japan
Segment Reporting Information [Line Items]
Net revenue	$ 555	478	$ 1,573	1,394
Change	16%		13%
Southeast Asia
Segment Reporting Information [Line Items]
Net revenue	$ 428	180	$ 827	590
Change	138%		40%
United States
Segment Reporting Information [Line Items]
Net revenue	$ 1,053	1,039	$ 2,665	3,203
Change	1%		(17.00%)
Europe
Segment Reporting Information [Line Items]
Net revenue	$ 339	$ 661	$ 1,038	$ 1,711
Change	(49.00%)		(39.00%)
Revenue | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Percentage of net revenue	100%	100%	100%	100%
Revenue | Asia Pacific | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Percentage of net revenue	79%	74%	82%	75%
Revenue | China | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Percentage of net revenue	32%	27%	40%	22%
Revenue | Korea | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Percentage of net revenue	16%	15%	16%	19%
Revenue | Taiwan | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Percentage of net revenue	17%	21%	14%	24%
Revenue | Japan | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Percentage of net revenue	8%	8%	8%	7%
Revenue | Southeast Asia | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Percentage of net revenue	6%	3%	4%	3%
Revenue | United States | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Percentage of net revenue	16%	16%	13%	16%
Revenue | Europe | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Percentage of net revenue	5%	10%	5%	9%

Industry Segment Operations - P

Industry Segment Operations - Percentage for Semiconductor Systems by End User (Details) - Revenue - Product Concentration Risk - Semiconductor Systems	3 Months Ended		9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023
Concentration Risk [Line Items]
Percentage of net revenue	100%	100%	100%	100%
Foundry, logic and other
Concentration Risk [Line Items]
Percentage of net revenue	72%	79%	66%	80%
Dynamic random-access memory (DRAM)
Concentration Risk [Line Items]
Percentage of net revenue	24%	17%	30%	14%
Flash memory
Concentration Risk [Line Items]
Percentage of net revenue	4%	4%	4%	6%

Industry Segment Operations - R

Industry Segment Operations - Reconciliations of Total Segment (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023	Jul. 28, 2024	Jul. 30, 2023
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Unallocated net revenue	$ 6,778	$ 6,425	$ 20,131	$ 19,794
Income from operations	1,942	1,802	5,821	5,683
Corporate and Other
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Unallocated net revenue	23	50	137	148
Unallocated cost of products sold and expenses	(276)	(247)	(839)	(782)
Income from operations	$ (253)	$ (197)	$ (702)	$ (634)

Industry Segment Operations -_4

Industry Segment Operations - Percentage by Customer (Details)	9 Months Ended
	Jul. 28, 2024
Customer Concentration Risk | Revenue | Samsung Electronics Co., Ltd.
Entity-Wide Revenue, Major Customer [Line Items]
Percentage of net revenue	12%